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Abstract
This study was to identify the critical role of advanced glycation and advanced 
lipoxidation end products in age-related RPE dysfunction in human eyes. Lipofuscin 
is an age pigment composed of incompletely degraded material derived from the 
photoreceptors and autophagy. With ageing, there is a gradual accumulation of 
lipofuscin pigment material in the lysosomal system within RPE that may have a 
direct influence on cell function.
Evidences appeared that AGEs/ALEs might play an important role in the 
formation of age-related intracellular fluorescence in RPE cells including that 
associated with lipofuscin granules. Also, they might appreciably alter the expression 
and enzymatic activity in the RPE lysosomal system, causing disruption of lysosomal 
function and having severe implications for RPE health in the ageing eye.
Our results showed there was a significant increase of auto-fluorescent 
granules accumulation in ARPE-19 cells after 28 days culture on glycated matrigel 
feeding with POS which means that AGEs/ALEs could increase lipofuscin 
accumulation within RPE in in vitro. These results were also confirmed by using 
primary RPE cells from 3 donors (male and female). Secondly, we also demonstrated 
that AGEs/ALEs accumulated within RPE could decrease Cathepsin D enzyme 
activities lead to cell dysfunction. Also Cathepsin B and APS activities were affected 
by AGEs/ALEs.
Results also showed that the lysosomal enzyme activities were deficient by 
AGEs/ALEs through altered the gene expression of the enzymes in the RPE 
respectively.
In summary, it has been demonstrated that the molecular and cellular 
function of the RPE could be transformed by non-enzymatic glycation.
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1.1 General Introduction
Advanced Glycation End Products (AGEs) are a heterogeneous group of 
structures. They are formed over time by a nonenzymatic Maillard reaction 
between primary amino groups and carbohydrate-derived aldehyde groups on 
proteins (Niorge et al., 1989). AGEs have been implicated in many of age-related 
diseases, such as: cataract, Alzheimer’s disease and atherosclerosis. Handa and 
colleagues (2001) quantified there was an age-dependent increase of AGEs in 
human Bruch’s membrane. They also identified AGEs were accumulated in basal 
deposits and drusen. From their report, they also determined that physiological 
dose of the AGE petosidine could up-regulate Platelet Derived Growth Factor p 
(PDGF-p) in retinal pigment epithelial (RPE) cells. This suggested that AGEs 
could influence the RPE phenotype.
Previous research showed that advanced glycation reactions appeared to 
play an important role in the age-related intracellular accumulation of 
autofluorescence and lipofuscin granules in post-mitotic epithelial cells (Stitt 2001; 
Vlassara et al., 2002). Lipofuscin is a heterogeneous chemically modified material. 
It is lipid aggregates and recognized within the human RPE cell as yellow-brown 
refractive granules. It is characteristically auto-fluoresce under short-wavelength 
light excitation (Feeney 1978). Lipofuscin has been considered to be a biomarker of 
RPE cell ageing because it can accumulate within the lysosomal system in a variety 
of post mitotic cells throughout life (Boulton et al., 1990). Furthermore, 
lipofuscin has been demonstrated to be able to inhibit lysosomal enzyme activity in 
vitro.
It is not similar like the other cells in the body. Lipofuscin accumulation in
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the RPE occurs through the autophagic breakdown of intracellular organelles. The 
major substrate for lipofuscin in the RPE of the eye is the un-degradable end 
product resulting from the phagocytosis of photoreceptor outer segments (POS) 
(Marmor et al., 1998). To study the development of the RPE of in vitro models has 
primarily focused on the auto-fluorescent materials accumulated in the RPE cells 
after phagocytosis of POS, which are delivered to the cells through the culture 
medium (Boulton et al., 1990).
In vivo, the continual digestion of the POS requires a high level of 
lysosomal enzyme activity in the RPE. Cathepsin D is the dominant Cathepsin in 
the RPE cell and it plays the most important role in the digestive process. Previous 
research shows that it is about 80% of POS are digested in the RPE by the 
Cathepsin D (Constable et al., 1997). Considering this large phagocytic load 
function, any effects causing the imbalance of Cathepsin D activity in the RPE cells 
could result in the accumulation of undigested POS phagosomes. This will 
ultimately cause morphological changes in the retina. To investigate the lipofuscin 
accumulation and other age-related changes in the RPE could help us to understand 
how ageing may adversely affect the function of the RPE cells.
1.2 The Retinal Pigment Epithelium (RPE)
1.2.1 Introduction of RPE
RPE is located between the neural retina and the choroids. It is a monolayer 
of cuboidal cells between the photoreceptors and Choriocapillaris of the eye and is 
specialized to uptake, phagocytize, and recycle the POS and retinaldehyde, the 
chromophore of rhodopsin (Osborne & Chader 1992). RPE cell death plays a major
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role in the pathogenesis of age-related macular degeneration, the leading cause of 
blindness in the population >60 years of age in the developed world (Osborne & 
Chader 1992). Possible reasons given for the degeneration of RPE cells are their 
exposure to high oxidative stress and damaging irradiation.
The RPE in adults is a non-dividing system. It sustains a number of 
functions essentially for the preservation of photoreceptor cells (Zinn & Marmor 
1979). The roles of RPE are: 1) establishment of a blood-retinal barrier, which 
controls the flow of metabolites and ions into and out of the retina; 2) phagocytosis 
and degradation of spent tips of photoreceptor outer segments; 3) absorption of 
optical radiation that has passed through the neural retina without being spent in the 
transduction process; 4) protection against free radical damage induced by high 
oxygen levels and light irradiation (Osborne & Chader 1992).
With ageing, the RPE in humans was seen to lose its light absorbing 
pigment-melanin and to accumulate the age-related pigment lipofuscin (Boulton et 
al., 1990). These changes were accompanied by the progressive accumulation of 
deposits within the underlying Bruch’s membrane (Boulton et al., 1990). These age 
related changes in the RPE and Bruch’s membrane have been implicated in the 
generation of Drusen and RPE detachment, which were associated with senile 
macular degeneration.
1.2.2 Structure and physiology of the RPE and Bruch’s 
Membrane
The RPE is derived from the outer layer of the optic cup. It is continuous 
with the anterior pigment epithelium of the ciliary body (Mann 1969). RPE cells
3
The Critical Role o f  A G Es/A LEs in Age-Related Dysfunction o f  the Retinal Pigm ent Epithelium C hapter 1
are haxano-cuboidal and are relatively regular in shape throughout the retina. It also 
has some variation in size and shape across the retina (Hogan et at., 1971). The RPE 
cells are polarized epithelium. They face the photoreceptor side with the apical side 
but the basal side faces to Bruch’s membrane (Hogan et at., 1971). Intracellular 
junction complexes are formed between neighbouring cells. They extend in a 
continuous fashion around the entire lateral membrane of each cell (Hogan et al., 
1971). The junction complex consists of two portions: an inner component being 
the zonulae occludes (tight junctions) and the outer zonulae adherents. Lateral 
membranes of the RPE also exhibit large numbers of gap junctions. They facilitate 
the transportation of fluid and metabolites from cell to cell (Osborne & Chader 
1992).
The RPE apical membrane is rich in two types of microvillus. One is a 
region that is highly complex in structure and rich in glycosaminoglycans (Bridges 
and Adler, 1985). It projects into the inter-photoreceptor space (Bridges and Adler, 
1985). Long thin microvillus covers the majority of the apical surface (5-7pm 
length). It has no contact with the POS. However, the photoreceptor sheath, which 
is a more specialized form of microvillus, is directly associated with the POS.
The basal membrane of the RPE lies on a thin flat basement membrane 
(0.3pm thick) (Bridges and Adler, 1985). The topography of basal membrane does 
not follow the infolding of the basal invaginations. There are large numbers of 
organelles contained in the RPE cytoplasm such as smooth endoplasmic reticulum. 
They are distributed throughout the cell (Bridges and Adler, 1985). The nuclei are 
ovoid and located towards the base o f the cell with large numbers of mitochondria.
Cigar-shaped melanin granules (size lx  2-3pm) are prominent feature in the 
apical and mid-portions of the cell. Lipofuscin progressively accumulates in the
4
Mement Epithelium  Chapter 1
central to basal portion of the cell as membrane bound granules (l~2pm) (Osborne 
& Chader 1992). Golgi bodies, primary and secondary lysosomes and peroxisomes 
are also contained in the RPE cytoplasm.
The retina remains closely appose to the RPE. However, the mechanism of 
RPE-retinal adherences has not been established yet, although it was thought to 
consist of a number of elements that complement each other. These include the 
viscous nature of the inter-photoreceptor matrix. It offers resistance to separation of 
the two layers. Figure 1.1 (deGuilebom &Zauberman 1972).
rods & cones
Diament
epithelium
photorecepto
outer _  
nuclear layer
ganglion cellmm axons
M outer - .  
plexiform layer;
inner - * i  - 
nuclear layer t <
inner 
plexiform layer 3
ganglion  ^j  
cell layer w
horizontal cells 
bipolar cells
am acrine cells
ganglion cells
Figure 1.1 Cross-sectional views o f RPE & neural retina. (deGuileborn &Zauberman 
1972)
The RPE cell layer forms a selective barrier to the free diffusion of ions and 
metabolites through the continuous belt o f tight junctions between the adjacent 
cells (Peyman et al., 1971). Thus, the molecular components of the extra-vascular 
fluid that leak from the fenestrated vessels of the chorio-capillaries are conveyed to 
the outer retina via a variety of selective trans-cellular transport systems.
5
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It is part of a system of barriers which maintain the composition of the 
intraocular fluids. The trans-epithelial transport properties of the RPE have been 
investigated predominantly in amphibian and embryonic chick preparations. It has 
provided a wealth of information that the RPE has developed a number of 
specialized systems for the movement of ions, fluid, amino acids, retinoid and 
carbohydrates between the retina and the chorio-capillaries.
The RPE can remove the spent tips of POS by a poorly understood 
mechanism throughout life. This probably differs between rods and cones (Young, 
1971). Some researchers suggested that there was an active ingression by the RPE 
sheath into the tips of the rod cells (Spitznas and Hogan 1970). The others proposed 
a simple engulfing role for the RPE in response to an active shedding of spent discs 
by the rods (Young, 1971).
1.2.3 The function of the RPE
1.2.3.1 Transport and Barrier Properties
The RPE is a multifunctional component of the retina. It performs 
numerous roles that are necessary for normal visual function. Many of the 
functional roles of the RPE are related to its unique location and to the metabolic, 
nutritive and barrier maintenance demands of the neural retina.
The RPE constitutes the outer blood-retinal barrier through its tight 
junctions. It forms a selective barrier to the free diffusion of ions and metabolites 
owing to the continuous belt of tight junctions between adjacent cells (Peyman et 
aL, 1971), and is responsible for the regulation and active transport of metabolites, 
such as glucose and amino acids from the choroidal circulation to the neural retina.
6
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The barrier also has a function to prevent unguarded influx of blood cells and 
potentially harmful blood-borne proteins, for example, complements and 
immunoglobulins. Therefore, the RPE has responsibility for maintaining the 
microenvironment o f the photoreceptors and the normal running of their 
surrounding matrix.
The trans-epithelial transport is achieved by various of specific membrane 
receptors on the apical or basal RPE plasma membranes (Hughes et al 1998; 
Bridges et al 2002,). For example, the RPE transports taurine to the sub-retinal 
space where it is specifically required by the photoreceptor cells (Miller & 
Steinberg 1976). Glucose is transported by GLUT1 glucose transporters, which 
are abundant in the apical and basal plasma membranes (Harik et al 1990). The 
RPE also regulates the passage of ions such as K+ and Na+ back and forth from the 
retina. This is important for the polarisation / hyperpolarisation of cell membranes 
and in the regulation of pH (Boulton & Dayhaw-Barker 2001).
It also helps to promote retinal adhesion by synthesis and preservation of 
the inter-photoreceptor matrix (IPM), which is composed o f highly structured 
material that contains large molecules such as proteins and glycosaminoglycans. It 
is an important mediator of photoreceptor outer segment integrity. The matrix is 
firmly attached to the external limiting membrane and to the apical surface of the 
RPE. The adhesive properties of the IPM are determined by the hydration and 
ionic situation of the local environment. Because the RPE actively pump ions and 
water out of the sub-retinal space, it keeps the outer retinal ionic/osmotic in 
balance. Oxygen and other gases can freely penetrate through the choroid passing 
the RPE to the photoreceptors.
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1.2.3.2 Antioxidant properties
The retina is particularly susceptible to cell damage by oxidative stress due 
to the presence of high oxygen tensions coupled with the continuous exposure to 
visible light which together provide ideal conditions for the formation of reactive 
oxygen species (Beatty et al 2000). Furthermore, photoreceptor outer segments 
contain high concentrations of polyunsaturated fatty acids that are readily oxidised 
(Bazan 1989, Miceli et al 1994, Tate et al 1995). The RPE has several defence 
mechanisms to protect against cellular damage by oxidative products with the first 
line of defence centred on limiting the intensity of light reaching the RPE. This is 
accomplished by macular pigment that filters out blue light (Beatty et al 1999) and 
by melanin that reduces overall light intensity (Sama 1992).
The pigment melanin, found in RPE cells, is a heterogeneous polymer 
consisting of various monomers believed to be oxidation products of dopa 
(dihydroxyphenylalinine) derived from tyrosine (Sealy, R.C. et al., 1980). Melanin 
contains intrinsic, indolesemiquinone-like radicals are reversibly photo-generated 
under visible or UV irradiation (Schmidt & Peisch 1986). RPE melanin serves a 
photo-protective role by absorbing radiation and scavenging free radicals and 
reactive oxygen species (ROS). Evidence also exists for a phototoxic role for 
melanin in RPE cells, especially in aged cells, including measurable ROS 
photoproduction. Apart from its photo-protective function, melanin in the RPE 
(and choroid) also plays an important role in helping to improve optical clarity by 
absorbing stray light to minimising light scatter within the eye.
The RPE is particularly rich in exogenous antioxidants, such as vitamin C, 
E, and endogenous cytoplasmic antioxidants, such as superoxide dismutase, 
catalase, glutathione peroxidase and melanin , which can further quench reactive
oxygen species (Handleman & Dratz 1986, Newsome et al 1994). These provide 
the RPE with strong antioxidant protection.
1.2.3.3 The Phagocytosis and Degradation o f Photoreceptor Outer Segment
Major function of the RPE is phagocytosis of rod and cone outer segment 
membranes (Elner et al., 1981). It is a crucial process for the continual 
replenishment of new membranes and maintenance of the photoreceptor cell layer. 
Rods and cones continuously undergo the renewal of their outer segments. They are 
synthesised in the endoplasmic reticulum of the inner segment and then transferred 
to the base of the outer segment for assembly into new membranous discs (Young 
1976). It is estimated that the turnover rate of rod outer segments is approximately 
10 days (Young 1971). Over a 24 hour period, approximately 2000 -  4000 outer 
segment discs are ingested by each RPE cell (Young & Bok 1969).
Phagocytic uptake is achieved through the interaction of the apical 
processes of the RPE with the shed outer segment membranes. The precise 
molecular mechanisms involved in outer segment binding and phagocytosis by the 
RPE are complex and are not completely understood. But some evidences have 
suggested that a number of different ligand receptor systems are likely to be 
involved.
After phagocytosis, the phagosome contents are subjected to lysosomal 
degradation within the RPE. This process can be initiated by both light and 
endogenous circadian mechanisms. The intracellular digestion is a biphasic 
process. It initiates with small primary lysosomes fusing with phagosomes to form 
phagolysosomes. Subsequently, small lysosomes fuse with one another to form 
larger lysosomes, which then interact with the phagolysosomes probably through 
pore-like structures (Bosch et al 1993). Lysosomes contain a combination of over
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forty degradative enzymes. Cathepsin D is considered to be the major protease 
responsible for degrading the rhodopsin rich disc membranes of shed outer 
segments (Regan et al 1980).
1.2.4 Ageing Changes in the RPE
1.2.4.1 Introduction
There are two symptoms of ageing in the eye, one is visual performance 
declined and the other one is progressively increasing incidence of disorders that 
affect most tissues in the eye (Marshall 1987). These ageing changes in the retina 
are thought to be major cause of blindness in the developed countries. For example: 
age-related macular degeneration (AMD). Many age-related changes in the RPE 
are readily identifiable by microscopy. Only recently there are more subtle changes 
identified, e.g. alterations in the spectral properties of pigment granules and 
lysosomal enzyme activities (Osborne & Chader 1992).
Most of the age-related changes in the RPE and Bruch’s membrane are 
strongly associated with the development of AMD. However, the evidence between 
normal ageing changes and disease is not clear because many of the age-related 
changes seen in eyes with AMD can also be seen in advanced age and may precede 
the onset of AMD. Therefore, it is very likely that a complex interplay between 
genetic and environmental factors affect whether an individual is going to develop 
AMD or not (Boulton & Dayhaw-barker 2001).
1.2.4.2 Cell Morphology and Cell Death
Cell death is occurring in the RPE monolayer throughout life. It is an 
integral part of homeostasis and plays a major role in degenerative and proliferate
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diseases (Hinsull and Bellamy 1981). There is a net reduction in the number of RPE 
cells across the retina with ageing even though the overall shape of RPE cells 
remain constant (Marshall 1987). Because the RPE is normally a non-dividing 
system, the insidious loss o f macular RPE cells due to ageing will be replaced by 
adjacent cells spreading to fill in the gap. The increasing cell area is associated with 
an increase in the height o f RPE cells (Feeney-Bum et al., 1984).
1.2.4.3 Melanosomes
The melanin content o f RPE cells shows a regional distribution. It decreases 
from the equator to the posterior pole with a significant peak at the macula 
(Feeney-Bums et al., 1984). There is a significant decline in the total number of 
melanin granules observed in all regions after the age of 40 (Feeney-Bums et al.,
1984). When compared among three age groups (1-20, 21-60, 61-100), the decline 
in melanin content in the macular RPE between the early and late samples was 
about 25% (Osborne & Chader, 1992). Although the melanin granules morphology 
is similar in all age groups, there is an age-related change in their spectral 
characteristics (Boulton et al., 1990).
1.2.4.4 Accumulation o f Lipofuscin
The accumulation of lipofuscin is one of the earliest and most distinctive 
features of ageing in the RPE (Katz & Robinson 1984). Lipofuscin is an 
auto-fluorescent intracellular material. It is composed of an ill-defined mixture of 
lipid and protein. It can account for up to 19% of RPE cytoplasmic volume in the 
later stage of life (Feeney-Bums et al 1984). So far, chloroform soluble 
fluorophore A2E is the only successfully identified component (Eldred & Laskey 
1993).
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Lipofuscin can accumulate in many post-mitotic cell types such as neurones 
and cardiac muscle (Merry 1987), but is particularly apparent in ageing RPE. There 
is a common perception that the ageing RPE has a diminished capability to degrade 
phagosomal particles (Marshall 1987). This has lead to the suggestion that 
lipofuscin granules represent the undigested end products of outer segment 
phagocytosis and autophagy (Rakoczy et al 1992, Wassell et al 1998). There is a 
hypothesis supported by the fact that accumulation of lipofuscin granules is most 
concentrated at the posterior pole (Wassell et al 1998). This corresponds with the 
area of highest density of photoreceptor outer segments and so supports the 
suggestion that outer segments are the primary substrate for lipofuscin (Wassell et 
al 1998).
The formation of Lipofuscin is a complex process and two alternative 
theories have been proposed to account for it. Firstly, it has been suggested that 
POS are oxidised prior to phagocytosis. It results in the fact that it cannot be 
completely degraded by the RPE lysosomal enzymes (Kennedy et al 1995). 
However, some research discovered that although oxidative damage to outer 
segments seemed to be involved in lipofuscin formation, further modification 
within the RPE might also be required (Katz et al 1993, Wassell et al 1998). 
Secondly, it is possible that a decrease in lysosomal degradative capacity could lead 
to an accumulation of lipofuscin. This suggestion was supported by the fact that 
protease inhibitor treatment of RPE resulted in an accumulation of lipofuscin like 
material (Katz & Shanker 1989). It is possible that an age-related alteration in 
enzyme expression and/or activity could promote lipofuscin accumulation.
Evidence has shown that the accumulation of lipofuscin in macular RPE 
areas increases from 1% in the first decade of life to 19% in the 81-90 year age
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group (Feeney-Bums et al 1984). Feeney-Bums’ study also showed that the 
greatest increase in lipofuscin granules in the RPE actually occurred in the first two 
decades of life (Feeney-Bums et al 1984). Boulton (et al., 1986) reported that if 
lipofuscin accumulation reached a critically high level, the RPE cell death was 
increased (Boulton & Marshall 1986). This supports the comment that lipofuscin 
and other complex granules accumulation may compromise normal cellular 
activity by causing an overall reduction in functional cytoplasmic space. Therefore 
the available volume for organelles is reduced and the cell can no longer perform its 
functions (Marshall 1987). It has also been proposed that lipofuscin is 
photo-reactive (Boulton et al 1993, Rozanowska et al 1995). Winkler’s (Winkler et 
al 1999). Research on a cellular system demonstrated that exposure of cells to both 
blue light and lipofuscin led to a decrease in cell viability, an increase in lipid 
peroxidation and a compromise of lysosomal integrity.
Lipofuscin accumulation in RPE mono cell layer has been thought to be 
associated with AMD. This pathogenic association is supported by the fact that 
both development o f AMD and accumulation of lipofuscin are correlated with age. 
There are massive lipofuscin accumulations showed in the atrophic form of AMD 
(Sarks 1988). At present there is no direct evidence to suggest that lipofuscin is 
involved with AMD because although lipofuscin accumulation happens on all 
human eyes, not all eyes develop AMD. This suggests that other intrinsic and/or 
extrinsic factors may be also involved in the pathogenesis of this complex 
condition.
1.2.4.5 Lysosomal Enzymes
Previous research found that the lysosomal fraction from the RPE was three 
times more active in degrading rhodopsin than the lysosome fractions from other
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cells (Zimmerman et al 1983). Moreover, it was also shown that in bovine RPE, the 
specific activity of acid lipase in the lysosomes was 10-fold higher than acid lipase 
activity in other bovine tissues (Hayasaka et al 1977) which represented an 
adaptation to the supra-high content of polyunsaturated fatty acids presented in the 
outer segments.
The lysosomal acid hydrolase’s activity has a regional variation. This 
probably reflects regional inconsistency in environmental factors, such as 
phagocytic load of RPE locate in peripheral, central retina or macula. There has 
been evidence to show that the RPE underneath the macular region shows 
particularly high specific activities of acid phosphatase, Cathepsin D and 
arylsulfatase when compared to other areas of the retina (Elayasaka et al 1981). 
These findings are consistent with a more recent study that confirms higher acid 
phosphatase and Cathepsin D activities in human RPE derived from the macular 
region than cells derived from the peripheral retina (Boulton et al 1994).
This can be explained that the enzymatic activity increases in different 
regions because of the amount of material to be phagocytosed. Regional variation 
has also been observed in other non-human species. Such as bovine RPE cells from 
the area centralise which have a higher Cathepsin D activity than cells from the 
peripheral retina (Burke & Twining 1988). In canine cells, regional distribution of 
enzymatic activity varies (Cabral et al 1990), Cathepsin D is highest in the central 
retina and acid phosphatase, p-glucuronidase and n-acetyl-|3-glucosaminidase are 
highest in the peripheral retina. It is obvious that, while there is some interspecies 
and regional variation, the lysosomal activity of RPE is highly specialised for 
lifetime degradation of POS. Previous research has shown that the lysosomal 
enzyme content and human RPE cell activity changed with age. The two lysosomal
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enzymes (acid phosphatase and Cathepsin D) have an increase in overall activity 
with age, as studied in freshly isolated RPE cells.
1.2.4.6 Bruch’s membrane
Bruch’s membrane lies between the outer retina and its metabolic supply, 
and changes on the inner surface of Bruch’s membrane are common finding in 
age-related retinal disease. Lipid accumulation in Bruch’s membrane has been 
observed in the donor eyes with ageing (Pauleikhoff et al., 1990). The staining of 
lipid is most marked in the macular region of eyes from the over 60-old-year age 
group. The collagen fibres become more numerous with age and the fibres’ atypical 
banding periodicity changes are also apparent in the Bruch’s membrane fibrous 
layer (Grindle and Marshall, 1978).
1.2.4.7 Drusen
As previously outlined, there is a potential link between accumulation of 
lipofuscin and the development of AMD. However the gradual accumulation of 
lipofuscin granules within the RPE is accompanied by build up of abnormal 
extracellular deposits beneath the RPE within Bruch’s membrane. This has lead to 
an alternative and increasingly strengthening theory that age-related changes in 
Bruch’s membrane could also be associated with development of AMD and other 
outer retinal degenerative disorders.
Most of the changes to Bruch’s membrane involve accumulation of 
abnormal material in the form of either discrete or diffuse deposits. These 
deposits, known clinically as drusen, constitute accumulations of extracellular 
material lying between the basement membrane of the RPE and the inner 
collagenous zone of Bruch’s membrane (Sarks et al 1994). Numbers of drusen
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have been correlated with increasing age (Sarks et al 1994). Where their 
accumulation may serve to elevate the RPE cell layer from Bruch’s membrane 
causing localised areas of detachment (Schwatrz et al 1998). Although the precise 
composition of drusen remains to be elucidated they are known to be composed 
mainly of mucopolysaccharides and lipid components, and Hageman’s report had 
shown that widespread drusen were the earliest ophthalmoscopic indicator of AMD 
initiation or progression and could be classified as hard or soft, discrete or 
confluent (Hageman & Mullins 1999). Hard drusen originate from the discharge 
of membranous debris from the RPE cells and reflect a localized disorder of the 
RPE (Green et al 1985). On the other hand, soft drusen are an indication of diffuse 
RPE dysfunction with pathophysiological impact on AMD initiation and 
progression (Green et al 1985). Figure 1.2
Figure 1.2 Fundus Photograph showing drusen accumulation (Green et a l , 1985)
Drusen, the clinical discrete spots, are a common finding in the macular 
region and in the far periphery of elderly eyes (Eagle, 1984). Hard drusen occurs in 
80% of post-mortem eyes (Coffery and Brownstain, 1986) and soft drusen with less 
well defined boundaries is usually larger than hard drusen and rarely occurs before 
the age of 55 (Gamer et al., 1994). Histochemical studies show that the 
fluorescein-excluding drusen are composed of lipids and protein deposits (Marshall
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1987). To date, there is no significant difference in the molecular composition of 
hard and soft drusen that have been identified which suggests that they may have a 
common origin (L.V. Johnson et al., 2003).
In advanced stages of AMD, hard drusen can coalesce to form confluent 
plaques that are associated with the atrophy of large patches of RPE and macular 
regions of retina (geographic atrophy) (Sarks SH 1982). Large numbers of drusen 
or large confluent drusen are also associated with a significantly increased risk of 
developing choroidal neovascularization, characteristic of the exudative (wet) form 
of AMD (Green WR et al., 1994).
1.2.4.8 Antioxidant Status
There has been much evidence to show that antioxidants implicated in the 
ageing process, and the antioxidant status, of the RPE is altered with age. 
Friedrichson’s research showed that the levels of the non-enzymatic antioxidant 
Vitamin E in macular RPE declined with ageing (Friedrichson et al 1995); Liles 
research showed that there was an age-related increase in activity of the antioxidant 
enzyme catalase in the RPE, but there was no change found for the RPE’s 
superoxide dismutase activity (Liles et al 1991). Antioxidant enzyme activity has 
also been correlated with lipid peroxidation as a function o f age (Castorina et al
1992). A progressive insidious change in antioxidant status could be a potential 
mechanism for age-related RPE cell dysfunction as it has been shown that 
oxidative stress can cause dysfunction and death in cultured RPE (Cai et al 2000).
1.2.4.9 Advanced Glycation
Advanced glycation endproducts (AGEs) have been implicated in the 
pathogenesis of a range of disease processes; the best known and most researched
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process is the role of AGEs in the development of the vascular complications of 
diabetes (Vlassara et al 1994; Stitt et al 1999, Jenkins et al 2002). However, more 
recently AGEs have also been linked with other diseases and degenerative 
disorders associated with ageing including atherosclerosis (Stitt et al 1997a, 1997b, 
1997c), Alzheimer’s disease (Munch et al 1998, 2002), male erectile dysfunction 
(Jiaan et al 1995, Seftel et al 1997), cataract formation (Harding & Crabbe 1984, 
Stevens 1978), osteoarthritis (DeGroot et al 2001) and pulmonary fibrosis 
(Matsuse et al 1998). Since the RPE and Bruch’s membrane are known to 
undergo significant changes with ageing and the fact that age is the only certain risk 
factor for development o f AMD, it is possible that advanced glycation may play 
either a contributory or facilitative role in development of age-related RPE 
dysfunction.
1.3 Age-related Macular Degeneration (AMD)
1.3.1.1 Introduction
Age-related macular degeneration (AMD) is the leading cause o f blindness 
in the Western world. It is the typical ageing changes that occurs in the RPE and 
Bruch’s membrane. It was responsible for approximately 95% of blindness and 
partial sight registrations in the UK (O’Shea 1998). Klein said this disease was 
prevalent in the elderly population (Klein et al 1992) and would become more 
common due to the fact that people would be living longer.
The Blue Mountains Eye Study in 1995 (Mitchell et al 1995) found that 
AMD percentage rose from 0% among people younger than 55 years of age to 
18.5% among those over 85 years of age. It was estimated that the percentage of
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people affected by AMD would almost double in the next 25 years (Stone et al 
2001). With an increase in elderly population in the future, there is no doubt that 
AMD will become a substantial social and public health problem in most Western 
societies (Klein et al 1992). The cause of AMD is still not clear, and the disease is 
extremely difficult for the ophthalmologist to treat in the clinic.
1.3.1.2 Concept o f AMD
There has not been a universally accepted definition for AMD. Previously, 
doctors and scientist tended to use the term of senile macular degeneration to 
describe many a variety o f changes in the macular region. Subsequently, the term 
age-related macular degeneration was adopted and referred to a group of late stage 
clinical symptoms that affect the macula.
The difficulty to define a concept for AMD is because AMD has a wide 
range of clinical features consistent with the diagnosis of AMD. The International 
Age-related Maculopathy study group proposed a classification system for early 
and late stages of the disease in 1995 (Bird et al 1995). They suggested that the 
term of age related maculopathy would be used to describe the early stages of the 
disorder which were characterised by drusen formation and pigmentary 
abnormalities, whereas they recommend that the term AMD would be reserved for 
later stages of the disease. AMD can then be further classified as the dry form 
(non-exudative) and the neovascular form (exudative) (Bird et al 1995).
1.3.1.3 The Macular Structure and Function
The macula is a circular zone located within the central retina with a radius 
of approximately 3mm, at the centre of which is the fovea (Young 1987). It is 
defined by a region of yellow pigmentation, and is also called yellow spot. The
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anatomical structure of macular has a number of differences compared with the rest 
of the retina. For example, the macula consists largely of cone photoreceptors. The 
photoreceptors density is highest in the retina. It also has a large number of 
populations of ganglion cells (Penfold et al 2001). The feature of having both the 
highest densities of photoreceptors and ganglion cell enables the macular to have 
high-resolution vision and acuity (Penfold et al 2001). As a result the macula is 
the area where the RPE is most metabolically active (O’Shea 1997).
The fovea region is located at the centre of the macula. It is the thinnest 
part of the retina as the inner nuclear layer. Ganglion cell layer and retinal blood 
vessels are displaced to ensure that there is no interference to the light that reaches 
the photoreceptors. In patients with AMD, it was estimated that about 90% of 
subretinal neovascular membranes are found close to the centre of the fovea 
(Berkow et al 1984). Therefore the highest visual acuity is affected by AMD.
1.3.1.4 The features o f  AM D
Histopathology and clinical pathology studies have evaluated the various 
morphologic features of AMD (Green et al 1985, Green & Enger 1993, Green
1999). Drusen formation and extracellular deposits beneath the RPE are the 
characteristic markers of AMD which cause pigmentary abnormalities and 
hyperplasia of the RPE. Significantly, all the major features of dry AMD can also 
be seen in people with normal ageing and are present in some form in almost all 
aged eyes, albeit to a lesser extent. The processes by which these changes occur are 
not well understood; the pathogenesis of AMD is complex and remains to be 
elucidated. It is highly probable that accelerated age-related changes in the RPE 
and Bruch’s membrane play a key role in the development of this disorder.
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1.3.1.4.1 Dry AMD (non-exudative)
AMD is either non-exudative (dry AMD) or exudative. Non-exudative or 
dry maculopathy is the most common form of AMD, accounting for 80-90% of 
cases (Sharon et al., 2002). Dry AMD is caused by the progressive degeneration of 
the RPE associated with secondary loss of the photoreceptor cells and results in 
either moderate or severe loss of central vision (Sunness 1999) (figure 1.3). Loss of 
the photoreceptors and RPE occurs slowly over time and consequently vision loss 
occurs as a gradual process.
Geographic atrophy of the RPE is the advanced form of non-neovascular 
AMD (Sharon et al., 2002). It is responsible for approximately 20% of the legal 
blindness caused by AMD, compared to choroidal neovascularisation accounting 
for the remaining 80% (Ferris et al 1984). At the present time there is no effective 
form of treatment.
M ac u I aj Degene ration
Figure 1.3 The yellowish deposits in the macula, known as drusen, are a classic 
sign o f dry macular degeneration. The dry type is much more common and is 
characterized by drusen and loss o f pigment in the retina. (Sharon et al, 2002)
Clinically it consists of one or more areas of RPE hypo-pigmentation with 
exposure of the underlying choroidal vessels (O’Shea 1998). Histological studies 
demonstrate that the RPE and photoreceptors are lost in the area of geographic
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atrophy (Sunness 1999). It is presumed that RPE degeneration occurs first, 
followed by secondary choriocapillary atrophy (Korte et al 1984); however, it has 
also been hypothesized that choroidal vascular dysfunction could be a primary 
event that leads to subsequent degeneration of the RPE. This theory is supported 
by recent evidence, which has shown that choroidal blood flow is compromised in 
dry AMD (Grunwald et al 1998).
1.3.1.4.2 Wet AMD (Neovascular AMD)
Exudative AMD is also known as “wet” or neovascular macular 
degeneration. In contrast to dry AMD, vision loss occurs much faster in patients 
with the neovascular form of the disease and central vision lost may be significant 
over a period of days (Bird et al 1995). Although they may also extend into the 
subretinal space, Neovascular AMD is caused by the rapid invasion of choroidal 
blood vessels through Bruch’s membrane into the sub-RPE space (Green & Enger
1993). Such choroidal neovascularisation causes sub-RPE haemorrhage resulting 
in an accumulation of blood or serum beneath the RPE and may lead to a RPE 
detachment (Campochiaro et al 1999). Serum or blood may then pass through the 
detached RPE to enter the sub-retinal space causing a serous or haemorrhagic 
retinal detachment (Campochiaro et al 1999). Choroidal neovascularisation can 
then produce a fibrovascular disciform scar.
22
;s/ALEs in Age-Related D ysfunction o f  the Retinal Pigm ent Epithelium Chapter I
Macular Degeneration
Figure 1.4 A tiny net o f  abnormal blood vessels has developed under the retina, 
causing bleeding and loss o f central vision (Green & Enger 1993)
This occurs when there is a proliferation of RPE cells associated with the 
new vessels. Sub-RPE or sub-retinal haemorrhage stimulates the scarring process 
by promoting the proliferation o f RPE cells and fibrous tissue beneath the new 
retina (Green et al 1985). The scar replaces the outer retina and then causes a 
permanent central scotoma in the RPE (figure 1.4) (Green & Enger 1993). 
Consequently neovascular AMD has a devastating effect on visual acuity.
1.5 Drusen and AMD
As mentioned previously, drusen is the main lesion associated with AMD 
(Sarks et al 1994). It represents the earliest feature o f the disease that can be 
detected by ophthalmoscopic examination (Bressler et al 1988). Presence of drusen 
is a significant risk factor for the development of AMD (Sarks 1980, Bressler et al
1994). The features such as the number, size, shape and distribution of sub-RPE 
deposits are important characteristics that can indicate greater risk of developing 
AMD. It has been shown that eyes with AMD exhibit softer, more confluent and 
larger drusen than normal age-matched control eyes (figure 1.5) (Spraul &
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Grossniklaus 1997).
Furthermore, particular types of drusen have been associated with different 
forms of late stage AMD and therefore may be of some prognostic importance. For 
instance, soft drusen have been associated with choroidal
Figure 1.5 The dry type is much more common and is characterized by drusen and 
loss ofpigment in the retina. Drusen are small, yellowish deposits that form within the layers 
of the retina (Spraul & Grossniklaus 1997) 
neovascularisation (Sarks et al 1994) and the presence o f large or numerous drusen 
are significant risk factors for development of late stage AMD (Holz et al 1994). In 
fact, the Beaver Dam eye study showed that 11.7% of patients who initially had 
large drusen developed late stage AMD after 5 years (Klein et al 1997).
1.3.1.6 Risk Factors for AMD
Large numbers of studies have been undertaken by researchers to try to 
identify the association of the risk factors of AMD and epidemiological aetiology 
of AMD. The three principal research studies based on large sample populations, 
the Beaver Dam Eye Study (Klein et al 1992), the Rotterdam study (Vingerling et 
al 1995) and the Blue Mountains Eye Study (Mitchell et al 1995) have provided 
reliable epidemiological evidences to establish which risk factors are associated
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with AMD. Cardiovascular disease, smoking, dietary factors, light exposure, 
genotype and ethnic origin have all been postulated as potential risk factors for 
AMD (O’Shea 1998). There is also evidence from many different studies that 
consistently shows that, as the name implies, age is the most important and only 
certain risk factor for AMD (Vingerling et al 1995, Mitchell et al 1995, Klein et al 
1992).
Among those implied risk factors, apart from age, cardiovascular disease is 
considered the most popular aetiology in AMD; this implies that AMD may be 
primarily a vascular disorder. The vascular model proposes that choroid vascular 
dysfunction increases the deposition of lipid in Bruch’s membrane. This 
mechanism is the similar to atheroma formation in the vessel wall of large vessels, 
which leads to deterioration of the overlying RPE (Friedman 2000).
Hypertension is considered to be one of many cardiovascular risk factors 
that could potentially damage the choroid blood vessels. Some other studies have 
found a relationship between uncontrolled blood pressure and AMD (Hyman et al 
2000). However, none of the three large population based studies found any 
significant relationship between hypertension and AMD.
Another cardiovascular risk factor, atherosclerosis, has also been linked to 
AMD. This relationship was investigated and certified in the Rotterdam study 
(Vingerling et al 1995). The Beaver Dam Eye study found that higher levels of 
dietary fat intake were associated with early stage AMD (Mares-Perlman et al
1995).
Smoking is another identified risk factor for cardiovascular disease and it 
has been consistently associated with AMD. It is hypothesized that smoking 
might lead to an increased risk of AMD either by directly affecting the choroid
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circulation or by decreasing the level of antioxidants in the blood (Evans 2001). 
There were numerous studies investigating the relationship between smoking and 
AMD; most of the results had found significant evidence linking smoking with 
AMD (Klein et al 1993, Vingerling et al 1996, Smith et al 1996). There was a lack 
of evidence, though, to support an association between other cardiovascular risk 
factors such as alcohol consumption or the effect of oestrogen with AMD.
In humans, diabetes is another cardiovascular risk but, surprisingly, it did 
not appear to have a significant relationship to AMD (Mitchell & Wang 1999, 
Klein et al 1992). However Bensaoula’s research showed that there were 
morphological changes in the RPE of diabetic rats (Bensaoula & Ottlecz 2001). 
Further studies from this research group uncovered a significant diabetes-induced 
deepening of the basal infolds and an increase in the amount of intercellular space. 
These significant clinical alterations are not yet observed but Bensaula speculated 
that the changes might be related to blood retinal barrier dysfunction in diabetes 
(Bensaoula & Ottlecz 2001).
Furthermore, the prevalence of macular drusen was reported to be high in a 
population of insulin dependent diabetics (Alexander 1985). Prospective research 
in recent decades on the development and risk factors for AMD had shown that 
visual acuity in patients with AMD deteriorated earlier in type 2 diabetic patients 
than in non-diabetic control patients. However, the frequency of AMD was 
approximately the same in both groups (Voutilainen-Kaunisto et al 2000). An 
interesting finding from the same study showed that AMD was an independent risk 
factor for cardiovascular mortality in type 2 diabetic patients. The relative risk for 
cardiovascular mortality in diabetic patients with AMD was almost five times 
higher than in non-diabetic patients without AMD (Voutilainen-Kaunisto et al
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2000). Therefore it is possible that AMD and cardiovascular disease have common 
precursors.
Further evidence to support a possible relationship between AMD and 
diabetes came from the discovery that some of the major pathologic features of 
AMD such as basal laminar deposits and choroid neovascularisation were often 
associated with choroid capillaries degeneration in diabetes (Cao et al 1998). It was 
also observed that the thickness of basal laminar deposits increased with increasing 
severity of choriocapillaris degeneration (Cao et al 1998). This confirms previous 
findings that choriocapillaris dropout and compromised choroid blood flow in 
diabetes was associated with basement membrane thickening (Hidayat & Fine
1985) and choroid neovascularisation (McLeod & Lutty 1994).
Exposure to light and antioxidant intake or supplementation may also be 
associated with an increased risk of AMD (Hawkins et al 1999). It is thought that 
over-exposure to light or abnormally low levels of antioxidants may result in higher 
levels of oxidative stress and as a result increase risk of AMD. A number of studies 
have examined the role of ultraviolet and/or visible light on the development of 
AMD (Taylor et al 1992, Cruickshanks et al 1993, Darzins et al 1997). It is 
extremely difficult to reliably measure exposure to light directly and therefore not 
surprising that no convincing evidence has been found (Evans 2001).
The role of antioxidants in AMD is equally inconclusive (Hawkins et al 
1999) and there is little evidence that antioxidant supplementation prevents or 
slows the progression of AMD (Evans 2001, Taylor et al 2002). There are several 
randomised controlled trials investigating antioxidant supplementation that are in 
progress, and hopefully should show some future lists in the role of antioxidants in 
AMD.
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In addition to the role of cardiovascular and environmental risk factors, 
there is mounting evidence to suggest that there is a genetic basis for AMD (Gorin 
et al 1999). As a result, there has been a great deal of research focused on 
attempting to identify the candidate genes that contribute to AMD risk. But there 
are difficulties in studying the role of genetics in AMD as, for example, AMD does 
not develop until old age. This means that large pedigrees are rare to achieve (Zack 
et al 1999). There is also a problem that AMD is likely to be a complex genetic 
disorder in which many genes (known and unknown) are implicated (Gorin et al 
1999). This even further complicated by environmental factors, which may modify 
a genetically determined risk for AMD (Gorin et al 1999).
Therefore, in addition to studying the genetics of AMD directly, another 
approach has been to study other retinal diseases with similar phenotypes such as 
Startgardt’s disease and Best’s disease (Zack et al 1999). Although none of the 
genes that cause these diseases have been found to account for a significant 
proportion of AMD, these studies can be used to gain insights into the pathogenesis 
of this disease (Stone et al 2001). An important recent development to indicate a 
genetic component of AMD is the reduced prevalence o f the s4 allele of 
apolipoprotein E (also linked to atherosclerosis) in patients with exudative AMD 
(Souied et al 1998 and Klaver et al 1998).
In conclusion, the aetiology of AMD is complex and there are many 
putative risk factors. At present, age is the best-understood and only definite risk 
factor for AMD although there is also strong evidence to implicate smoking in the 
development of AMD. For the other hypothetical risk factors, there is either 
insufficient or conflicting evidence to support the association with AMD. Future 
studies could help to establish the most influential genetic and environmental
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contributions to the pathogenesis and aetiology of this disease.
1.3.1.7 Current Understanding and Treatment For AMD
As outlined briefly above, the pathogenesis of AMD remains ill defined. At 
present there is no established treatment that can effectively restore vision in AMD. 
The dry form of AMD represents a slow atrophy of the cells within the macula. At 
present, there is no definitive treatment other than risk factor management. These 
methods include: 1) reducing consumption of vegetable oils; 2) stop of smoking; 3) 
reduction in body mass index (BMI); and 4) taking specific vitamin supplements 
(ie. antioxidants, omega-3) (Packo, 2004). The Age Related Eye Disease Study 
(AREDS) provided the best evidence for antioxidant supplementation particularly 
for unaffected eyes or early stage AMD (Coleman. H & Chew E 2007). However, 
in most instances these measures only slow the progression of the condition. 
Interestingly, the AREDS formulation also showed a 30% risk reduction in 
unaffected fellow eyes o f patients with wet AMD (H Coleman & Chew E 2007).
Epidemiologic data are still clear about the fact that age-related macular 
degeneration (AMD) is the leading cause for substantial and irreversible vision loss 
among the populations o f developed nations (Klein et al., 1992; Mitchell et al., 
1995; Vingerling et al., 1995). Due to the rapid aging of the western population, 
this number is expected to double by the year of 2020 (Friedman et al., 2004). 
Although neovascular AMD only accounts for about 10-20% of the total AMD 
incidence, it is responsible for 90% of cases of severe vision loss (Votruba and 
Gregor, 2001). The management o f neovascular AMD will therefore become an 
important challenge for patients, ophthalmologists and the health systems.
In recent years, research has provided new insights into the pathogenesis of 
macular disease. In combination with the rapidly growing knowledge about basic
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mechanisms in angiogenesis, this accumulating knowledge has led to novel 
developments in therapeutic strategies resulting in a widening of available 
treatment options and improved prognostic perspectives (Ursula et al., 2007). 
About ten years ago, the only proven treatment for choroidal neovascularization 
(CNV) was laser photocoagulation applicable only in a rather small proportion of 
patients (C. H. Meyer 2007). Today less destructive treatments directly targeting 
the CNV component and its pathogenic cascade have become available.
It is the first time in the history of AMD therapy that intravitreally 
administered antibodies against vascular endothelial growth factor (VEGF) offer a 
significant chance of an increase in visual acuity to patients affected with 
neovascular AMD. Today, anti-angiogenic approaches can provide long-term 
vision maintenance in over 90% and substantial improvement in 25—40% of 
patients (Q. Mohamed et al., 2007). New treatment, such as RNA interference or 
even gene therapy hold a positive promise to improve treatment outcomes in the 
near future.
So far, two anti-VEGF drugs have been currently available on the market: 
bevacizumab (Avastin) and ranibizumab (Lucentis). Bevacizumab and 
ranibizumab have very similar structurre. Bevacizumab is a full size recombinant 
antibody molecule initially engineered and approved for the treatment of colorectal 
cancer (Q. Mohamed et al., 2007). As designed for systemic infusion, it has been 
shown to have a significant side effect profile (mainly hypertension and 
thromboembolic events) (Rich et al., 2006). However, the minute intravitreal doses 
used for treating AMD, to date, have shown essentially no measurable toxicity 
(Avery et al., 2006; Rich et al., 2006)
On the contrast, Ranibizumab is derived from its parent molecule-
30
The Critical Role o f  A G Es/A LEs in Age-Related Dysfunction o f  the Retinal Pigm ent Epithelium Chapter 1
bevacizumab. It consists of the FAB binding fragment of the same antibody 
molecule targeting VEGF (Rich et al., 2006). Ranibizumab is specifically 
designed for use in the treatment of AMD. In mouse models, FAB binding 
fragments have been shown to have greater retinal penetration than full size 
antibody molecules, presumably due to its reduced size (Mordenti et al., 1999). The 
side effects and administering doses for ranibizumab have been studied in a large 
randomised controlled trial (Heier JS et al., 2006). These appear to be the only 
theoretical advantages of one over the other. Both drugs seem to show similar 
clinical effects when using optical coherence tomography (OCT) images as a guide 
to treatment responses.
There are also some other new drugs undergoing evaluation all around the 
world. These include pegaptanib (Macugen) and anecortave acetate (Retaane). 
Pegaptanib is another agent directed at inhibiting the specific isoform 165 of VEGF 
(Bird M et al., 2007). Its use as an independent agent is confounded by the fact 
that the majority of initial study eyes had already been treated with verteporfin 
PDT. The studies did not seem to show the same degree of visual improvements 
seen with drugs such as ranibizumab (Gragoudas et al. 2004).
Anecortave acetate is an angiostatic cortisene compound designed to block 
the migration of proliferating endothelial cells by inhibiting metalloproteinases. 
Phase III randomised, double masked data showed anecortave acetate to be no 
better than standard verteporfin PDT (Slakter et al., 2006). Neither pegaptanib nor 
anecortave acetate is set to be marketed in the world. They are undergoing further 
trial to become available for clinical application.
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1.4 AGEs/ALEs and Tissue Dysfunction
1.4.1 What Are AGEs/ALEs
Advanced Glycation end products are forms of heterogeneous group of 
irreversible adducts comes from reactive derivatives of nonenzymatic 
glucose-protein condensation reactions, as well as lipids and nucleic acids exposed 
to reducing sugars. They were originally characterized by their yellow-brown 
fluorescent colour and their ability to form crosslinks between amino groups 
(Vlassara et at., 1984). It is now used for a broad range of advanced products of 
the Maillard Reaction (Njorge et al., 1989). The compounds include such as 
(3,4,)A^-^carboxymethyl') lysine(CML) and pyrraline, which neither show colour 
and fluorescence, nor occur as cross-links in proteins (Reddy et al., 1995). The 
formation of AGEs in vitro and in vivo are both dependent on the turnover rate of 
the chemically modified target, time and sugar concentration.
1.4.2 Risk Factors
1.4.2.1 Age
Advanced glycation end products are a subgroup of the non-enzymatically 
derived crosslinks. They are the latest products that modify proteins and nucleic 
acids by reducing sugar, and they have been shown to accumulate slowly in 
Bruch’s membrane as well as accumulating at renal and vascular smooth cells, 
which progressively increases in thickness throughout life and at a more rapid rate 
in diabetes (Li et al., 1996).
Such findings have contributed to the prevalent view that random
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modifications of protein molecules cause a generalized decrease in metabolic 
efficiency occurring during senescence. In some subjects, this may contribute to 
choroidal neovascularization, or to geographic atrophy with consequent visual loss 
(Marmor & Wolfensberger, 1998).
1.4.2.2 Diet
Recent studies show that AGEs/ALEs can be introduced to biological 
systems from exogenous sources. This may have significant impact on disease 
mechanisms. Diet is the major source of exogenous AGEs/ALEs, with the highest 
content in complex foods, such as those rich in carbohydrates and fats (Vlassara. et 
al., 2002). Formation of AGEs/ALEs is enhanced by exposure to heat; this is 
responsible for the browning of food as it is cooked, increasing with cooking 
temperature and duration.
Koschinsky and colleagues (1997) showed that AGE immuno-reactivity 
could increase by 200-fold in egg-white cooked with fructose compared with 
egg-white prepared identically in the absence of fructose. This study also 
confirmed the absorption of 10% of ingested AGE and showed that only one-third 
of that absorbed was excreted within 48 hours in the urine o f patients with normal 
renal function. The AGEs that are not cleared by the kidney were distributed to the 
tissues where they remained biologically active. This data implies that dietary 
AGEs may pose a significant environment risk, particularly to patients with 
nephropathy (Kischinsky et al., 1997).
1.4.2.3 Smoking
Smokers have a significantly higher risk for developing coronary and 
cerebrovascular disease (Carla, et al., 1997). As tobacco leaves are dried in the
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presence of sugar, a process called curing (Vlassara & Palace, 2000); the Maillard 
reaction causes the formation of glycated and oxidized derivatives. After 
combustion, reactive AGE species are volatilized (Vlassara &Palace 2000). The 
species, also termed ‘glycotoxins’, react with protein, exhibit a specific 
fluorescence when cross-linked to protein and are mutagenic are inhaled, absorbed 
through the lungs and become conjugated with serum proteins including 
lipoproteins.
This was reflected in the fact that total serum AGE and AGE-apoprotein (3 
levels in cigarette smokers were found to be significantly higher than in 
non-smokers. This suggests that increased glycotoxin exposure might contribute to 
the increased incidence of atherosclerosis, lens optical density (Hammond, 1999) 
and ocular disease (Cheng, et al., 2000)
1.4.2.4 Alcohol/Ethanol
Epidemiological studies suggested that there was a beneficial effect of 
moderate ethanol consumption on the incidence of cardiovascular disease (Yousef 
et al, 1998). Upon ingestion, alcohol/ethanol is oxidatively metabolised by alcohol 
dehydrogenase to produce acetaldehyde. It can react with nucleotrophes to form 
covalent additional products, which is chemically reactive. Its activity in modifying 
macromolecules has been hypothesised to contribute to certain organ toxicities 
associated with chronic ethanol abuse (Yousef et a l, 1998).
Yousef and colleagues identified a biochemical modification produced by 
the reaction of acetaldehyde with protein-bound Amadori products. Amadori 
products typically arise from the nonenzymatic addition of reducing sugar to 
protein amino groups and are the precursors to irreversibly bound, cross-linking
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moieties (AGEs).
1.4.2.5 Protein Glycation
The nonenzymatic reaction of the amino groups of amino acids, peptides 
and proteins with reducing sugars to form a complex family of rearranged and 
dehydrated covalent adducts, that are often seen as yellow-brown and/or 
fluorescent and include many cross-linked structures, was first studied under 
defined conditions by L.C. Maillard in the early 1990’s It is termed the Maillard 
reaction or advanced glycation (Ulrich, et al., 2001).
Food chemists have long studied the process as a source of flavour, colour, 
and texture changes in cooked, processed, and stored foods. During 1970’s and 
1980’s, it was realised that this process also occured slowly in vivo. AGEs are 
implicated in causing the complications of diabetes and ageing, primarily via 
adventitious and cross-linking of protein (Morgan, et al, 2002)
1.4.2.6 Oxidative processes
The ageing process or senescence is characterised by a ubiquitous decline in 
the functional capacity of various physiological systems. It is perhaps most 
noticeably manifested in the loss of motor ability and the stamina for sustained 
physical effort (Head, 2002). Ageing is a consequence of the accumulation of 
random oxidative damage to cellular molecules, caused by reactive oxygen or 
nitrogen species, produced under normal physiological condition.
Many studies have found that the oxidative modifications clearly affect 
nuclear and mitochondria DNA, they are also readily observed in proteins (Liang, 
et al. 1997). Oxidative modified proteins are generally dysfunctional, losing 
catalytic or structural integrity. Thus, oxidative damage to protein is considered to
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be a key of importance in ageing. A linear relationship between subject age and the 
amount of protein carbonyl groups has been found in the human eyes lens cortex by 
Fancesco (2000).
1.4.3 Chemical Background of Glycation and AGEs/ALEs 
Under Physiological Conditions
1.4.3.1 Biochemistry o f  AGE Formation
1.4.3.1.1 The Maillard Reaction-the source of endogenous AGEs/ALEs
AGEs are formed by a complex series of nonenzymatic glycation reactions. 
AGE formation is initiated by the nucleophilic addition of a reducing sugar such as 
glucose to a free amino group. The free amino group could be the N-terminal amino 
group of a protein or the s-amino group of the amino acids lysine or arginine, 
Although glycation reactions can also occur on free amine containing lipids and on 
DNA. In any case, this reaction results in an unstable Schiff base, which undergoes 
rearrangement to form a more stable Amadori product.
Amadori product formation is also known as glycation. Therefore, any 
protein which attached by Amadori Products is characterised as a glycated protein. 
It is important to notice that this is not as the same as an enzymatically glycosylated 
protein (Ulrich & Cerami 2001. Early glycation products, such as
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Figure 1.6 Formation o f protein-bound nonenzymatic glycosylation products 
Glucose (in the open-chain form) reacts with amino groups on proteins, lipids or DNA to form  
unstable intermediates such as Schiff bases and Amadori products, which are freely reversible 
and exist in equilibrium. Further condensation and oxidation reactions lead to formation of  
AGEs, which are irreversible and are formed over a longer time (H. Vlassara & M.R. Palace
2002).
Schiff bases and Amadori-products are chemically reversible. They are in 
equilibrium with glucose, and are fairly stable and have half-lives of days and 
weeks (Figure 1.6). These properties allow the level of glucose derived Amadori 
products to be a good indicator of blood glucose control over a period of weeks. 
Hence it is used as the routine clinical measurement of HbA lc levels of diabetic 
patients (Koenig et al 1976).
But, as Amadori products exist in equilibrium, after they have reached a 
steady state, they do not increase over time (Vishwanath et al 1986). That means 
the levels of Amadori products in diabetic patients are no more than 2-3 fold higher 
than in non-diabetic patients (Kato et al 1989). Consequently, it has been suggested 
that it would be more reliable to measure AGE-modified haemoglobin as it is 
irreversible and reflects glucose control over a longer period of time (Makita et al 
1992).
Consequently, following the Amadori rearrangement the product can either
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undergo further reactions to form advanced glycation end products or it can be 
broken down to regenerate the intact amine, in which case the sugar component 
goes on to form highly reactive dicarbonyl compounds, for example like glyoxal, 
methylglyoxal or deoxyglucosones (Thomalley et al 1999). These compounds are 
intermediates that propagate the Maillard reaction. They are an important source of 
AGEs because they form an alternative pathway that leads to the formation of many 
AGE structures (Thomalley et al 1999).
Early and advanced glycation
Amadori
+  RNH 2 Rearrangement
Reducmg sugars SchiffsBase .*7 Fructosamine
R N H2
and/or
ARG
AGEs/ALEs
Glycolytic intermediates ^  pero3adation
(methylglyoxal, 3D-G) (^yoxal, mediyl^oxal)
Figure 1.7 Diagram o f  Formation o f AGEs: AGEs and the related advanced 
lipoxidation endproducts (ALEs) can occur through a number o f  inter-related pathways, 
some o f which can lead to very rapidformation o f these adducts.(A. W. Stitt 2003)
The Maillard reaction processes give rise to these AGEs is not well 
understood. Although it is known that following the Amadori rearrangement, 
further dehydration, cross linking and condensation reactions occur and result in 
the formation of advanced glycation end products. These products are 
thermodynamically stable, and thereby irreversible and permanent. For this reason, 
they accumulate over time (Figure 1.7). On account of these properties, AGEs are 
predisposed to accumulate on proteins with long half-lives and are capable of 
forming covalent bonds with amino groups on other proteins (A.W. Stitt et al
2003).
The formation of AGEs is proportional to time and sugar concentrations.
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This means that AGEs may form very quickly if reactive sugars or intermediates 
are at high levels (Thomalley et al 1999). Therefore, the hyperglycaemia in 
diabetes results an accelerated rate of formation of AGEs. However, it is also 
important to know that advanced glycosylation reactions occur with ageing even 
under normal blood glucose levels, which results in an increasing of AGEs’ levels 
with ageing.
1.4.3.1.2 Major Exogenous Sources of AGEs
Recent studies suggest that AGEs introduced to biological systems from 
exogenous sources, such as diet and smoking may have significant impact on 
disease mechanisms. Diet is the major source of exogenous AGE with the highest 
content in complex foods, such as those rich in carbohydrates and fats. The 
formation of AGE is enhanced by exposure to heat; thus AGE content, which is 
responsible for the browning of food as it cooks, increases with cooking 
temperature and duration. Whilst the abundance of dietary AGEs including 
methylglyoxal (MG) and Carboxymethyl lysine (CML) has long been recognized. 
Their significance as potential toxins was not appreciated as their absorption was 
estimated to be only approximately 10% of that ingested (Stitt 2001).
Smoking seems to be another source of orally administered exogenous 
AGEs, since the level of AGE modified proteins in the semm of cigarette smokers 
is significantly higher than in non-smokers (cerami et al 1997); also significantly 
increased serum AGE levels have been observed in diabetic smokers compared to 
diabetic non-smokers (Baumgartl et al., 1996). It is reasonable to say that breaking 
the course of the AGE can be supported by an antioxidant diet and a healthy life
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style.
Figure 1.8 Schematic representation o f the fate o f diet-derived AGEs. Cooked 
foods contain sugar-derived protein or lipid glycation intermediates that may include 
noncrosslinking products, such as N-v-carboxymethyl-lysine (CML), pyrroles, imidazoles, 
pyridines (left insert), or crosslink forming, reactive intermediates (glycotoxins), such as 
1-,3-deoxyglycozone (3-DG), methylglyoxal, protein-linked A-P-dione (right insert). The 
former are presumably readily excreted in urine, whilst the latter may reattach onto serum 
or tissue components to form new AGEs with the eventual pathological consequences. 
( Vlassara, et a i, 2002)
It has been found that food AGEs can be absorbed after eating (figure 1.8). 
In Koschinsky’s research in 1997, food-derived AGEs with cross-linking activity 
could accumulate in serum to a significant degree, implying that normal kidney 
function is important to protect from dietary AGEs.
Further in vivo evidence comes from studies on hyper-cholesterol mice, 
which found that mice fed a low-AGE diet had a reduced vessel wall response to 
arterial injury, indicating that dietary AGEs may enhance susceptibility of various 
tissues to disease (Lin et al 2002). These studies indicate that exogenous sources of 
AGEs may be important pathways for many disease processes.
1.4.4 Biopathogenesis Relation to AGEs/ALEs Formation
1.4.4.1 The Cellular Action o f  AGEs
AGE-Protein
1 and 3-DG 
Methylglyoxal 
A-P-dione
Kidney
Urine
New Tissue AGE
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AGE formation was originally thought to specifically tag senescent 
proteins, thereby providing a specific signal for recognition, degradation and 
removal of senescent macromolecules (Vlassara et al., 1994). The low molecular 
weight AGE-rich peptides (LMW-AGE) were identified as degradation products 
and were presumably released into the circulation to be cleared by the kidneys 
(Yang et al., 1991). The interactions of AGE modified proteins with different AGE 
receptor complexes were studied. They not only served to degrade AGE-proteins, 
but also activated signal transduction pathways that induced the synthesis and 
released of cytokines and growth factors that might initiate tissue repair and protein 
turnover (Vlassara et at., 1994).
Intracellular AGE formation occurs extremely fast because intracellular 
sugars are much more reactive than glucose. Giardino reported in 1994 that 1 week 
in vitro and in vivo incubation o f endothelial cells in the presence of high glucose 
levels resulted in a 13.8-fold increase in the intracellular AGE content. In parallel, 
the mitogenic activity of high glucose cultivated endothelial cells markedly 
decreased. The observed loss in mitogenic activity was due to post-translational 
modifications of basic fibroblast growth factor (BFGF) by AGEs, representing the 
major AGE-modified protein in endothelial cells (Giardino et al., 1994).
The extracellular matrix AGE formation results in decreased elasticity; 
increased thickness; rigidity; breaking time and narrowing of the vessel lumen 
(Bierhaus et at., 1997). Binding o f AGEs to their cellular binding sites resulted in 
depletion of cellular antioxidant defence mechanisms and the generation of oxygen 
free radicals.
1.4.4.2 AGE-Induced DNA Rearrangement
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Lee and Cerami reported in 1990 that AGEs could form on DNA, 
particularly on guanine residues to induce unusual DNA rearrangements. The 
strains o f G.coli that accumulate high levels of glucose-6-phosphate, is particularly 
active in forming AGEs (Lee and Cerami, 1991). Some evidences have also been 
found in mammalian cells that AGE formation on DNA may be responsible for 
insertions containing repetitive sequences of the Alu family that have been found to 
disrupt human genes (Bucala et al., 1993a). It has important implications that the 
possibility of AGEs may induce genetic rearrangements in vivo; for example, as a 
possible cause of congenital malformations in infants of poorly controlled, 
insulin-dependent, diabetic mothers (Lee et al, 1995)
1.4.4.2.1 AGEs Involved in Ocular Diseases
There are a large number of evidences showed that AGEs were also 
involved in the pathogenesis of ocular diseases. Many o f the cells and tissues of 
the eye are severely affected by diabetes and ageing, thereby non-enzymatic 
glycation has been implicated as an important process in several different ocular 
diseases (Stitt 2001).
The role of non-enzymatic glycation in cataract formation is the most 
widely researched. This is because the fact that lens crystallins are proteins. They 
have very long half-lives and have been used extensively for studying the effects of 
non-enzymatic glycation in vivo (Stitt 2001). There was a substantial amount of 
evidence to show that there were increased amounts of AGEs in aged and diabetic 
lenses (Harding & Crabbe 1984, Stevens et al 1978, Matsumoto et al 1997, Stitt 
2001). Levels of AGE crosslinking were high in aged and cataractous lenses with 
brunescent lenses (Chellen et al 1999). AGEs contributed to cataract formation by
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crosslinking the lens proteins leading to aggregate formation (Chellan et al 1999, 
Shamsi et al 2000).
AGEs may also be involved in modifications of the cornea in diabetes 
(Sady et al 1995, Kaji et al 2000) and ageing (Malik et al 1992, Malik & Meek 
1994). AGEs have been immunologically identified in the comeal epithelial 
basement membrane, which is heavily glycated in diabetics (Kaji et al 2000). An 
in vitro model o f glycated basement membrane has shown that nonenzymatic 
glycation of laminin on a culture dish can decrease adhesion and spreading of 
comeal epithelial cells (Kaji et al 2000). Furthermore, human comeal collagen 
contains significant AGE levels that increase with ageing and are accompanied by 
structural changes such as increased cross-linking and increased collagen 
intermolecular spacing (Malik et al 1992). Many of these structural changes can be 
inhibited by inhibitors o f protein glycation such as aspirin-like compounds and 
certain vitamins (Malik & Meek 1994, 1996). Advanced glycation has also been 
implicated in the development of vitreous pathology (Sebag et al 1992). Vitreous 
AGE levels have been shown to increase with age in non-diabetics and in diabetics 
(Stitt et al 1998). Similar to the comeal situation, the collagen component of the 
vitreous gel is also subject to modification by advanced glycation. This process can 
also be prevented by the use of an AGE inhibitor (Stitt et al 1998). It appears that 
this non-enzymatic glycation of collagen causes dissociation from hyaluronan and 
consequently causes destabilisation of the complex vitreous gel stmcture (Stitt
1998).
AGEs are also thought to have significant effects on the retinal vasculature. 
AGEs have been localised to the retinal vessels in diabetes and so may have a role 
in the development of diabetic retinopathy (Stitt et al 1998). Levels of the defined
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AGE adduct CML have been correlated with diabetic retinopathy (Stitt 1997, Ono 
et al., 1998, Chiarelli et al., 1999). Similarly increased levels of pentosidine in 
skin also correlate with severity of diabetic retinopathy (Chiarelli et al., 1999). A 
number of studies have shown that AGEs can induce wide-ranging effects on 
retinal cells. Nitric oxide synthase expression by retinal endothelial cells is 
inhibited by AGEs (Chakravarthy et al 1998).
AGEs can also cause calcification of retinal pericytes (Yamagishi et al
1999) and can modulate cell growth (Ruggeriero-Lopez et al 1997, Chibber et al 
1997). At low concentrations they can be mitogenic to retinal endothelial cells 
increasing the cell proliferation, while at higher concentrations, they can have a 
toxic effect (Chibber et al 1997). AGEs can stimulate cell proliferation through 
the induction of retinal vascular endothelial grow factor (VEGF) (Lu et al 1998, 
Hirata et al 1997). VEGF is also required for angiogenesis and so AGEs are 
thought to participate in the pathogenesis of diabetic retinopathy through their 
ability to increase retinal VEGF expression (Yamaguishi et al 1997). Finally, as 
stated previously, there is a growing amount of evidence to associate the 
accumulation o f AGEs with age-related dysfunction of the RPE and Bruch’s 
membrane, which may be important in the pathogenesis of AMD.
1.4.4.2.2 AGEs/ALEs in RPE Ageing
The relationship o f AGEs and ageing is based on the observation that 
reactive AGE adducts accumulate on the extracellular matrix and in the 
intracellular compartment of target cells (Stitt & Vlassara, 1999). By the Maillard 
reaction, AGEs can form on the amino groups of proteins, lipids and DNA and also 
by reactive dicarbonyls formed via auto oxidation of sugars, lipid oxidation and 
many metabolic pathways’ by-products (Baynes et al., 2000). ALEs are the
44
protein-lipid peroxidation and dicarbonyl reaction products. They commonly form 
in concert with AGEs. Their pathogenic role in ageing has a strong links between 
oxidative and glycation reactions.
Odetti et al., (1998) have identified that AGEs/ALEs accumulated in 
lipid-rich CNS cells with ageing. Because the RPE-resides in a highly oxidative 
environment and constantly phagocytoses lipid/protein rich photoreceptor 
membranes, it would be expected that AGEs and ALEs would accumulate in large 
amounts in both the intra- and extracellular compartments of the RPE with 
increasing age.
1.5 R e s e a r c h  A im s & O b j e c t iv e s
The evidence suggests that accumulation of advanced glycation end 
products in combination with advanced lipoxidation end products with ageing may 
play a significant, pathogenic role at the RPE-Bruch’s axis. Therefore we 
hypothesise that AGEs/ALEs may have a critical role in age-related dysfunction of 
the RPE. In order to address our hypothesise, our main objectives are:
1. To investigate AGEs/ALEs accumulation in ageing RPE cells
2. To identify the effects o f AGE-modified sub-cellular matrix on RPE cell 
function
3. To study the pathgocytic and degradative capacity of RPE exposed to 
AGEs/ALEs.
4. To evaluate the kinetics o f key lysosomal proteinases in RPE cells after 
AGE/ALE-exposure and the correlation with lipofuscin accumulation.
5. Gene expressions of the key lysosomal proteinases will be analysed before and 
after cells have glycation treatment.
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Chapter 2. In Vitro Assay to Identify the 
Effects of AGEs/ALEs on Lipofuscin 
Accumulation in RPE Cells;
2.1 Introduction
Current research has found that the most important function of the RPE is 
the phagocytosis and degradation of photoreceptor outer segments, which is 
essential to maintain healthy photoreceptor-cell function. It has been estimated 
that a single RPE cell can phagocytose and degrade approximately 2000 -  4000 
outer segment membranous discs each day (Bok & Young 1969). This 
impressive workload for the RPE may also play a significant role in many 
age-related diseases in the retina. In fact, a large amount of evidence suggested 
that the lysosomal system of the RPE could suffer significantly during the ageing 
process and be subject to dysfunction. This may be presented by decreased 
degradation of POS, increased lipofuscin deposition and drusen formation in the 
sub-RPE space (Hayasaka 1983).
Research by Feeney L (1978) and Boulton M (1991) have demonstrated 
that lipofuscin is a lipid-protein aggregate that was present within the human 
retinal pigment epithelium as yellow-brown refractile granules showing a 
characteristic fluorescence under short wavelength light. Lipofuscin granules are 
thought to represent the lifelong accumulation of lysosomal residual bodies 
containing the end products of phagocytosis of POS (Katz Ml et al., 1986) and, to a 
lesser extent, of autophagy (Feeney L 1978). The intracellular accumulation of 
these granules, which can constitute as much as 19% of RPE cytoplasmic volume
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in later life (Feeney-Bums L et al., 1984), has been implicated in the development 
of age-related macular degeneration (Boulton M 1991).
There is also increasing evidence to suggest that AGEs may have an 
important role in age-related RPE dysfunction. So far, AGEs have been identified 
and known to be endocytosed by many cell-types, after which they are directed to 
secondary lysosomes (Mori et al 1995, Araki et al 1995; A.W. Stitt et al 2000) and 
it has been shown that AGEs accumulate in the lysosomal compartment in other 
non-retinal cell types (Figure 2.1).
Numerous studies, both in vitro (Boulton et al., 1989; Rakoczy et al., 1992; 
Burke and Brzeski-Skumatz, 1996) and in vivo (Eldred and Katz, 1988; Katz and 
Nomberg, 1992), have investigated the mechanisms involved in the formation of 
RPE lipofuscin. These studies assessed the accumulation of cellular 
autofluorescent granules and interpreted this to be indicative of lipofuscin 
formation.
In this chapter, the contribution of photoreceptor outer segments and 
autophagy to granule formation was assessed by 1) feeding RPE cells with POS 
(vary concentrations) and in long-term RPE cell culture with and without glycated 
condition (vary glycation conditions). The degree of the protein and lipid 
components of these substrates in granule formation was determined by flow 
cytometer.
48
2.2 Materials
ARPE-19 cells were obtained from stocks held in Professor Mike 
Boulton’s lab. All human eyes came from the Bristol eye bank. Chemicals were 
purchased from the suppliers listed in Appendix II.
2.3 Methods
2.3.1 Primary RPE And ARPE-19 cell Culture
2.3.1.1 Primary RPE cell culture
All human eyes (which received full permission for research use 
according to UKTS guidelines) were collected from the Bristol eye bank. The 
donors used in this study were a 58 year old male, a 69 year old male and a 73 
year old female. All eyes were enucleated less than 48 hours post-mortem as RPE 
cells could only be cultured from eyes that had been enucleated and dissected less 
than 48 hours post-mortem. After prior removal of the corneas for transplantation 
at Bristol eye bank, under sterile conditions in a laminar flow cabinet, eyeballs 
were circumferentially dissected approximately 2mm posterior to the limbus and 
the anterior portion of the eyes was discarded.
The process was that each of the remaining eyecups was placed in a sterile 
eye-cup-holder after gentle removal of the lens, vitreous and the attached neural 
retinal. The RPE layer was then exposed to 1 ml of 0.25% trypsin-EDTA 
(appendix II) and incubated at 37°C for 40 minutes in a 60ml polyethylene pot. 
The RPE cells were detached by gentle agitation using a 3ml plastic Pasteur 
pipette. The resultant cell suspension was added to 5ml serum-containing growth 
medium (Ham’s F10 nutrient mixture supplemented with 10% FCS + 1%
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antibiotics and fungizone) (appendix II) to inactivate the trypsin-EDTA.
The cell suspension was then split, according to pellet size, between a 
numbers of wells in a 24-well plate. Plates were then incubated at 37°C in a CO2 
incubator (95% air, 5% C02) for approximately 7 days to allow attachment. The 
growth medium was subsequently replaced with fresh growth medium every 
three or four days and the RPE cells were regularly observed through an inverted 
microscope until the cells reached 70% confluence. After confluence, cells were 
detached by Trypsin-EDTA and sub-cultured in 25 cm cell culture flask for 
experiment. Primary RPE cell cultures became passage 1 after splitting. The 
purity of the primary RPE cells was confirmed by immunostaining using 
pancytokeratin.
2.3.1.2 ARPE-19 cell Culture
ARPE-19 cells, which was from a 19 year old male donor, were obtained 
from an established, spontaneously transformed cell line (ATCC number: 
CRL-23027), through selective trypsinisation of a primary RPE culture resulting 
in a uniform population of highly epithelial cells exhibiting strong growth 
potential (Dunn et al., 1996). It is an immortalised cell line which has transformed 
and altered growth properties. The cells are no longer divided because of DNA 
damage or shortened telomeres. This means that it will not enter replicative 
senescence - ie that it will not stop growing even when it is kept passing it and is 
viable after a large number o f passages. As ARPE-19 cells came from the primary 
cell culture, it has the similar structural and functional properties as RPE cells in 
vivo, for example, it keeps the similar phagocytosis ability of POS, so that they 
can be used as model for in vitro studies of RPE physiology.
The same growth medium was used as the primary RPE cultures and the
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same incubation conditions. More precisely, the growth medium from the cells 
(in 75cm flasks) of confluent RPE cell cultures was aspirated and then the cells 
were washed with PBS. Then the cells were detached by the addition of 3ml 
trypsin-EDTA and incubated at 37°C for approximately 2 mins. The detachment 
of the cells was monitored under an inverted microscope. The trypsin-EDTA was 
then inactivated by adding 3ml of growth medium to re-suspend the cells. The 
suspension was then split between flasks (at a ratio of 1:3) and thus, the cell 
numbers were amplified. The ARPE-19 cells at passage 1, for example, then 
became passage 2. The purity of the ARPE-19 cells was confirmed by ATCC.
When primary RPE cell cultures and ARPE-19 cell cultures reached 
confluence, they were trypsinised again and either a) centrifugation at 1 OOg for 5 
mins at 4°C after washing with PBS, the cell pellet was re-suspended and stored 
in 10% FCS +l%DMSO containing growth medium in liquid nitrogen as passage 
2 cells (the cells were gradually brought down to sub-zero temperatures using a 
container filled with isopropanol and stored at -80°C for 24hours before storage 
in liquid nitrogen); or b) split into 6-well plates using 10% FCS +1%  antibiotics 
containing growth medium for experimental purposes.
2.3.2 Isolation of Photoreceptor Outer Segments (POS)
POS were isolated by the method described by Papermaster (1982) 
from light-adapted bovine eyes obtained from a local abattoir. The anterior 
portion of the eye was removed by circumferential incision and the vitreous was 
discarded. By detaching from the optic nerve, the retina was collected in a 
cryovial. A total of 50 retinas were collected. All the collected retinas were then
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frozen at -20°C for later use.
Frozen retinas were thawed at RT and 10ml retina homogenising medium 
(appendix II) was added per 7 retinas. The retinas were then homogenised using a 
handheld homogeniser and the resultant homogenate was centrifuged at 1900g 
for 4 minutes at 4°C (Burkard Koolspin centrifuge) producing a pellet of cellular 
debris. The supernatant was then collected and diluted to three times its original 
volume with 0.01M tris-acetate buffer, pH 7.4, and centrifuged at 1900g for 4 
minutes to produce a pellet of crude POS. This pellet was re-suspended in 0.5ml 
of a l.lOg/ml sucrose solution containing 50pl) each of 0.1 M MgCl2 and 1.0M 
tris-acetate buffer.
A discontinuous sucrose gradient was then made using 6ml each of a 1.11, 
1.13, and 1.15g/ml sucrose solution (Appendix II). The previous suspended pellet 
of crude POS was laid onto the top o f the gradient and centrifuged at 103,000g for 
30mins at 10°C. After centrifugation, the POS which appeared as an opaque 
white band located between the 1.11 and 1.13g/ml interface were removed using 
a sterile syringe and washed 3 times by PBS 1900g for 5minutes at 4°C. After 
that, the POS were re-suspended in growth medium with 2% FCS + 1% 
antibiotics and fungizone and stored at -20°C until use.
The number o f POS/ml was determined using a haem ocytometer. 
Duplicate samples were counted from each isolation.
2.3.3 Analysis of Autofluorescent Granules Generated in Cultured 
RPE cells (Primary and ARPE-19) Following Challenge with 
POS
2.3.3.1 Sample preparation
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Table2.1 The plan o f feeding RPE cells with POS in different time point and conditions
day 1 Medium Medium +POS 1X106 Medium +POS IX 107
day 7 Medium M edium +POS 1X106 M edium +POS 1X107
day 14 Medium M edium +POS 1X106 Medium +POS IX 107
day 28 Medium Medium +POS 1X106 M edium +POS 1X107
ARPE-19 and primary cell cultures were carried out by culturing at 37°C 
in T75cm flasks in the absence of bright light. Materials were prepared under 
standard laboratory lighting (fluorescent strip lights) and all experiment were 
repeated at least three times.
The confluent (80-90% confluence) Primary RPE (PI) and APRE-19 
cells were detached by 5ml of 0.25% trypsin-EDTA in T75cm culture flasks and 
then 5 ml of Ham’s F10 Medium (10% FCS+1% antibiotics and fungezone) was 
added to each flask to neutralise the trypsin-EDTA. After centrifugation at 4°C of 
lOOg to remove the trypsin- EDTA, cells were resuspended by 150 ml (T75 flask) 
of Ham’s F10 Medium (10% FCS+1% antibiotics and fungezone). Then, 3ml of 
the mixture of cells was transferred into 6-well plates containing Ham’s F10 
Medium (10% FCS+1% antibiotics and fungezone). The medium was changed 
every 3-4 days until the cells reached confluence; then the culture medium was 
changed to Ham’s F10 medium with 2% FCS + 1% antibiotics and fungizone for 
24hours. Thereafter, the medium with 2% FCS+1% antibiotics and fungizone 
were used for each experimental procedure.
2 3 3 .2  Challenge of RPE cells with POS (Primary and ARPE-19)
POS were diluted with Ham F10 medium (2% FCS+1% antibiotics) from 
stock concentration to lx l0 8/ml and lx l0 9/ml. For a negative control, only 4ml of 
culture medium was added in each well. For lx l0 6/ml concentration treatment of
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POS, 3.96ml of medium and 40pl of lx l0 8/ml POS were added in each well (2 
wells). For lx l0 7/ml concentration treatment of POS, 3.96ml of medium and 
40|xl of lx l0 9/ml POS were added in each well (2 wells). Medium with and 
without POS was changed every 2 days until the end time point of the experiment 
(i.e. day 1, 7, 14, 28).
2.3.3.3 Flow Cytometry
The mean autofluorescence per population of RPE cells was determined 
by using a fluorophotometric flow cytometer (Benton Dickson FACS analyser), 
based on the method of Rakoczy et al. (1992). Basically, the generation of 
autofluorescent granules of 10,000 RPE cells was measured using an excitation 
wavelength of 488nm, monitoring emission wavelength at 530nm. 
Measurements were taken less than 1 hour after cells were harvested and the data 
was analysed by using Cell Quest Software and single histogram statistics. The 
cell population to be analysed was selected by gating, using the samples 
trypsinised at Day=0; only samples selected within the same gate were compared.
After ARPE-19 and primary RPE cell culture had reached the experiment 
time points, the culture medium was removed by aspiration and then 200pl of 
Trypsin-EDTA were added to each well and incubated in a 37°C incubator for 
about 2 minutes to detach the cells. After that, 2ml of PBS with Ca+2 and Mg+2 
were added to re-suspend the cells which were then transferred into a 10ml glass 
centrifuge tube and centrifuged at 25Og for 4 minutes at 4°C. The supernatant was 
gently poured out until about 500pl of PBS was left. The PBS was mixed with 
cells gently which were then analysed for the accumulation of auto fluorescent 
granules by flow cytometer
2.3.3.4 Light/Fluorescence microscopy and photography
Samples prepared as described in section 2.2.3.1 were photographed at 
each experiment time point under both light and fluorescence (blue light) 
microscopes.
2.3.4 Analysis of Auto-fluorescent Granules Generated in RPE 
Cells (Primary and ARPE-19) Cultured on Advanced 
Glycated Extracellular Matrix fed with POS
2.3.4.1 Preparation of advanced glycated extracellular matrix
AGE-modified subcellular matrix (AGE-matrix) was prepared as
described by Kuyuza et al (1998). The frozen reconstituted basement membrane 
extract matrigel (Becton Dickenson) was defrosted overnight on ice in a fridge at 
4°C and diluted 1:10 with Ham’s F10 basal cell culture medium. Aliquots of 
0.5ml diluted matrigel were added to wells in a 6-well plate and allowed to 
polymerise for 1 hour at 37°C in the cell culture incubator (95% air + 5% CO2).
Glycation of matrigel was achieved through exposure of the matrigel to 
glycoaldehyde (Sigama-Aldrich Co., Ltd. UK) (50, 100, 150 and 200 mM in 
PBS) for 4 hours at 37°C in the incubator. For a negative control, only PBS was 
added to the well. The glycation reaction was stopped by adding 50mM final 
concentration of Sodium Bromide to each well at 37°C for 2 hours. The glycated 
matrigel was then rinsed twice with PBS to remove un-reacted glycoaldehyde 
and bubbles. Gels were then ready for cell culture experiments.
2.3.4.2 Samples preparation
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Table2.2 The plan o f RPE cells cultured on glycated matrigel feeding with POS with different
concentrations and time scales
MGEL
ONLY 50m M GA lOOmMGA 150mMGA 200m M GA
dav 1
1 X 1 0 6 
and 1X107
1X10 6 
and 1X107
1 X 1 0 6 
and 1X107
1 X 1 0 6 
and 1X107
1 X 1 0 6 
and 1X107
day 7
1X10 6 
and 1X107
1X10 6 
and 1X107
1X10 6 
and 1X107
1 X 1 0 6 
and 1X107
1 X 1 0 6 
and 1X107
day 14
1 X 1 0 6 
and 1X107
1X10 6 
and 1X107
1X10 6 
and 1X107
1X10 6 
and 1X107
1 X 1 0 6 
and 1X107
day 28
1 X 1 0 6 
and 1X107
1X10 6 
and IX 1 0 7
1X10 6 
and 1X107
1 X 1 0 6 
and 1X107
1 X 1 0 6 
and 1X107
Briefly, confluent Primary (P2) and APRE-19 cells (P2) were detached 
using 5 ml oftrypsin-EDTA in T75cm2 culture flasks and incubated in the 37°C 
incubator with 5% CO2 for 2 minutes. Then, 5 ml o f Ham’s F10 Medium (10% 
FCS+1% antibiotics and fungizone) was added to each o f flask to neutralise the 
trypsin-EDTA. After centrifugation at 4°C of lOOg to remove the trypsin- EDTA, 
cells were resuspended by 150 ml (each of T75cm flask) o f Ham’s F10 Medium 
(10% FCS+1% antibiotics and fungizone). Then 3ml of the mixture of cells was 
transferred into the 6-well glycated matrigel plates. Ham’s F10 Medium (10% 
FCS+1% antibiotics and fungezone) was changed every 3rd day until the cells 
reached confluence. Then the culture medium was changed to Ham’s F10 
medium with 2% FCS + 1% antibiotics and fungizone for 24hours. Thereafter, 
the medium with 2% FCS+1% antibiotics and fungizone were used until the end 
of each experimental time point.
RPE cells were challenged with POS as described in section 2.3.3.2. 
Culture medium with and without POS were changed every 48 hours until the end 
time point of the experiments (day 1,7, 14, 28).
56
The Critical Role o f  A G Es/A LEs in Age-Related D ysfunction o f  the Retinal Pigm ent E pithelium chapter 2
2.3.4.3 Flow Cytometry
Parameter setting of FACS was the same as in section 2.3.3.3. After 
ARPE-19 and primary RPE cultures reached the appropriate experimental points, 
the culture medium was removed by aspiration and then 200pl of Trypsin-EDTA 
were added in each well and then incubated in a 37°C incubator for about 2 
minutes to detach the cells. Afterwards, each of 2ml of PBS (with Ca+2 and Mg+2) 
was added to re-suspend the cells which were then transferred into a 10ml glass 
centrifuge tube for centrifugation at 250g for 4 minutes at 4°C. The supernatant 
was gently poured out until about 500pl of PBS was left. The PBS was mixed 
with cells gently and then auto-fluorescent granule accumulation generated by 
feeding POS to RPE cells (Primary and ARPE-19) was analysed by flow 
cytometry.
2.3.4.4 Light/Fluorescence microscopy and photography
Samples preparations for microscopy were as described in section 2.3.3.4. 
At each time point, photographs were taken under both a light and fluorescece 
Microscope (blue light).
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2.4 Results
2.4.1 Light/Fluorescent Microscopy and Photography
2.4.1.1 Primary Cell Isolation and Culture
The primary RPE cells isolated from fresh eyecups (post mortem time 
less than 48hrs) formed a suspension of pigmented cells when cultured in 24-well 
plates. After one week incubation at 37°C (95% air + 5% C02), some of cells had 
begun to attach to the bottom of the well. This was confirmed using an inverted 
microscope (Figure 2.1). Figure 2.1 showed that the cells had very clear 
cytoplasm and typical RPE irregular shape, there were some yellow brown 
pigments could still be seen, but the pigment disappeared after a few passage 
cultures.
Figure 2.1 Primary RPE cells isolatedfrom a 58 year's old male donor cultured 
on 24-well plate after 12 daysa Magnification x20
Two weeks later, more RPE cells had attached and the previous attached 
cells had begun to divide and form new colonies o f primary RPE cells. There was 
no fibroblast cells contamination. If contamination occurred with choroidal 
fibroblastes, these could be identified under the microscope due to their
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formation of spindle-shaped cells with a striated appearance (cultures would be 
discarded).
By the third week, the RPE cells had divided to become nearly confluent
in the wells (figure 2.2). At that point, they were harvested by following standard
•  •  * 2 • protocol as described previously, and sub-cultured in T75cm flasks containing
10% FCS + 1% antibiotics + 1 % fongizone in Ham F10 growth medium.
Figure 2.2 Primary RPE cells isolatedfrom a 58 year’s old male donor cultured 
on 24-well plate after 21 day and cells were nearly confluent. Magnification 
x20
When the cells reached confluence in the flasks, they were harvested as 
previously described and used for experimental purposes or stored in liquid 
nitrogen.
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Figure 2.3 Negative (a) and positive (b) staining for pancytokeratin in primary 
RPE cell culture. Magnification x40
Upon immunostaining of RPE cells, the cultures that stained positive for 
pancytokeratin fluoresced green under UV light using the TRITC filter in figure
2.3 b. This confirmed the purity of primary RPE cell cultures. Negative controls 
in figure 2.3(a) did not stain for pancytokeratin and thus there was no 
fluorescence observed.
2.4.1.2 ARPE-19 Cell culture
ARPE-19 cells have similar morphologies to primary RPE cell culture 
(figure 2.4). They reached confluence in 6-well plates in just 3-4 days and in 
T75cm2 flasks in approximately 4-6 days in 10% FCS containing growth medium
(figure 2.5).
'/SsiS,'
Figure 2.4: ARPE-19 was cultured after 2 days from splitting (a) and cultured after 7 
days splitting (b). Magnification x20
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After reaching confluence, they cells were trypsinised and either stored in 
liquid nitrogen as described for primary RPE cells or maintained at confluence in 
6-well plates for experimental purposes.
2.4.2 Flow cytometry for Analysis of Auto fluorescent
Granules Generated in Cultured RPE cells 
(Primary and ARPE-19) Following Challenge with 
POS
2.4.2.1 Flow Cytometry
The accumulation of auto-fluorescence granules was examined by flow
cytometry. The excitation wave length was 488nm and emission wavelength was 
530nm. In order to find out what would be the ideal concentration to feed the RPE 
by POS to mimic the pathophysiological conditions in vivo, RPE cells were fed 
by lx 104/ml, lx l0 5/ml, lx l0 6/ml, lx l0 7/ml and lx l0 8/ml o f POS respectively. 
Dot plot graph (a) showed the major similar cell populations within the gate and 
histograph (b) showed the increase of autofluorescent granules within the RPE 
cells (peak shifted from left to right).
1023
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Figure 2.5: ARPE-19 cells cultured 24hours fed  with lx l(f/m l POS and auto 
fluorescence granules analysed by flow cytometry. The circle region represents live 
cell; most ARPE cells were dead after 24 hours fed  with lx l(f/m l of POS
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Figure 2.5 showed that after 24 hours of the ARPE-19 cell fed with POS
o
1x10 /ml, most of the cells were dead. This could be seen in the gated region that 
represented the live cells. Cell death was also confirmed by staining the cells with 
trypan blue and checked under light microscope ( dead cells showed positive blue 
staining). By comparing with cells fed with lx l0 6/ml and lx l0 7/ml POS and 
control, there was a significant increase of autofluorescence granules generated in 
ARPE-19 cells (median=279.1) even though there were so many cells dead. This
Q
suggested that the 1x10 /ml concentration POS were too high to mimic the in vivo 
environment of RPE and may not be suitable for use in the following 
experiments. ARPE-19 cells fed with lx l0 6/ml and lx l0 7/ml POS showed that 
cells could survive well even cultured until 28 days. Flow cytometry results are 
shown in figures 2.6- 2.17.
1 0 -  10 
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Figure 2.6: ARPE-19 cells cultured 24hours without feeding with POS and the 
autofluorescent granules analysed by flow cytometer. Circlular zone represents 
live cells.
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Figure 2.7: ARPE-19 cells cultured 24 hours feeding with POS lx l(f/m l and 
the autofluorescent granules analysed by flow cytometer. Circular zone 
represents live cells.
ARPE-19+ROS10 7(241®)
Figure 2.8: ARPE-19 cells cultured 24 hours feeding with POS lx l0 7/ml and 
the autofluorescent granules analysed by flow cytometer. Circular region 
represents live cells.
|AKPE-19M«bnnonM7DAY<)
Figure 2.9: ARPE-19 cells cultured 7 days without feeding with POS and the 
autofluorescent granules analysed by flow cytometer. Circle region represent 
live cells.
FL1-H«c*t
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Figure 2.10: ARPE-19 cells cultured 7 days after feeding with POS lxl(f/m l 
and the autofluorescent granules analysed by flow cytometer. Circle region 
represent live cells.
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Figure 2.11: ARPE-19 cells cultured 7 days after feeding with POS lx l0 7/ml 
and the auto fluorescent granules analysed by flow cytometer. Circle region 
represent live cells.
ARPE 19!>(<aaiiiu » M )4 D A Y i'
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Figure 2.12: ARPE-19 cells cultured 14 days without feeding with POS and the 
auto fluorescent granules were analysed by flow cytometer. Circle region 
represent live cells
FL1 -Height
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Figure 2.13: ARPE-19 cells cultured 14 days after feeding with POS 1x1 (f/ml 
and the autofluorescent granules analysed by flow cytometer. Circle region 
represent live cells.
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Figure 2.14: ARPE-19 cells cultured 24 hours after feeding with POS lx l  O'/ml 
and the auto fluorescent granules analysed by flow cytometer. Circle region 
represent live cells.
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Figure 2.15: ARPE-19 cells cultured 28 days without feeding with POS and the 
autofluorescent granules were analysed by flow cytometer. Circle region 
represent live cells.
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Figure 2.16: ARPE-19 cells cultured 28 days after feeding with POS lxl(f/m l 
and the auto fluorescent granules were analysed by flow cytometer. Circle 
region represent live cells.
ARPE 19.SOS137(28DAT»)
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Figure 2.17: ARPE-19 cells cultured 28 days after feeding with POS lx l  O'/ml 
and the auto fluorescent granules were analysed by flow cytometer. Circle 
zone represent live cells.
POS of lx l0 4/ml and lx l0 5/ml were used for the experiment but results 
did not show significant auto-fluorescent values compare with control, which 
means they may not good enough for this project, it is likely that the 
concentrations of POS were not suitable to represent the ageing processing in 
RPE in vivo. Results were not shown.
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characteristic or age-related changes, the isolated primary RPE cells from a 58 
year old male donor were also used in the same treatment conditions. Results 
showed a similar trend compared with that shown in figure 2.19. These results 
support our previous results in ARPE-19 cell line. As there were not enough cells 
from this donor, experiments could not be repeated from this donor cells, so there 
was not enough statistics available to tell if the increase was significant or not.
Primary RPE Cells Fed with POS Day1-28
O Medium
□ 1x1 0 6
□  1X10 7
day 1 day 7 day 14 day 28
D ays
Figure 2.19: Primary RPE cells (58 year-old male donor) fed  with lx l(f/m l and 
lx l0 7/ml POS every 48 hours after confluence for 1, 7, 14 and 28 days. Auto 
fluorescent granule accumulation were analysed by flow cytometry. Cells were 
dead after 14 days o f challenge by lx l0 7/ml (no statistic data).
It is unknown why after 14 days feeding with 107/ml POS cell death 
occurred. Repeat experiments are necessary to determine this by using the other 
donor’s cells. Results showed in section 2.4.3.1.
2.4.2.2 Light/Fluorescence microscopy and photography
ARPE-19 and primary RPE cells fed with POS lx l0 6/ml and lx l0 7/ml 
after day 1, 7, 14 and 28 were also checked under an invert light/fluorescence 
microscope. Under the light microscope, after 1 day culture the cells look 
growing well with clear cytoplasm, similar with control. After day 7, 14 and 28,
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from the figure 2.20, there was a high density of dark granules (size varies) 
accumulation seen in the RPE cell cytoplasm and the increase was POS dose 
dependent. Some granules were also observed in the control group but not as 
much as cells fed with POS.
A
Figure 2.20: ARPE-19 cells after feeding with POS for  7 days. Cells were 
washed with PBS and photographs were taken under an invert 
light/fluorescent microscope, (a): cells withoutt fed  with POS (b) Cells fed  
with l(f/m l POS and (c) cells fed  with l0 7/ml POS. Magnification x40
Photographs in figure 2.20 a, b and c show the cells after 7 days feeding 
with and without POS (106/ml and 107/ml). The photographs could not be taken
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under fluorescence microscope as there were only yellow-green background 
colour could be seen. This might because the auto-fluorescent granules were not 
large enough to be seen under microscope or the magnification of the microscope 
was not big enough.
2.4.3 Analysis of Autofluorescent Granules
Generated in RPE Cell (Primary and 
ARPE-19) Cultured on Advanced Glycated 
Extra-cellular Matrix fed POS
2.4.3.1 Flow cytometry
Based on the pilot study’s protocol, the ARPE-19 cell lines and primary 
cells were treated as section 2.4.2. Similar results were seen for cells cultured on 
glycated matrigel after 28 days feeding with POS. Cell autofluorescence was 
increased significantly when cultured on glycated matrigel and they were POS, 
time and glycation concentrations dependent. See figures 2.21; 2.22; 2.23. (P 
values less than 0.01)
A R P E - 1 9  + M G E L  & G A  ( S 0  - 2  0 0 u M ) w i t h o u t  
F e e d i n g  w  I t h P O S
2 0 0
1 7 0  -
1 * 0 -  I S S O M G L
-  B K i]  S 0 n  M « M t d l u m
1 , , ,  ■ ■  1 0 0  m M i  M e d i u m
*  a a i l S O i i  M •  M e d i u m
|  ■ ■ 2  0  0  11 M •  M e d i u m
Day
Figure 2.21: ARPE-19 cells were cultured on glycated matrigel plates for 28days 
without feeding POS. Accumulation o f auto fluorescent granules was analysed 
at dayl, 7 ,14 and 28 by flow cytometry
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After 28days of culture ARPE-19 cell line on with and without glycation 
matrigel only with no feeding POS, the auto-fluorescent granules were increased 
greatly compare with control. For example, in 28 days culture, the means from 
control was only 19.4 but in cells cultured on matrigel only were 30 (50mM GA), 
39.5 (lOOmM GA), 42 (150mM GA) and 44 (200mM GA) respectively.
A R P E - 1 9  + M G E L  & G A ( S O - 2  0 0 u M )  F e e d i n g  w i t h  1 x 1 0  * / m I 
POS
>MOl
I M G I  ♦ R O S  1 O' / f f l  I 
I 5 0 m  M « R O S  1 o ' / m l  
I 1 0 0 m  M ♦ R O 8  1 0 * / m  I 
I 1 5 0 m M ♦ R O 8  1 0 * / m  I 
I  2 0 0  m M ♦ R 0 8  1 O ' / m  I2 |
a ■ ih  Mil ill
D a y
Figure 2.22: ARPE-19 cells were cultured on glycated matrigel plates for 28days 
with feeding POS lx l( f  /ml every 48hours. Accumulation o f auto fluorescent 
granules was analysed at day 1, 7,14 and 28 by flow cytometry
After 28days of culture ARPE-19 cell line on with and without glycation 
matrigel feeding lx l0 6/ml POS, the auto-fluorescent granules were increased 
greatly compare with control. For example, in 28 days culture, the means from 
control was only 19.4 but in cells cultured on matrigel only were 42.5, 62.25 
(50mM GA), 80.75 (lOOmM GA), 80.25 (150mM GA) and 74 (200mM GA) 
respectively.
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Figure 2.23: ARPE-19 cells were cultured on glycated matrigel plates for 28days 
with feeding POS lx l  O'/mlfor every 48hours. Accumulation o f auto fluorescent 
granules was analysed at day 1, 7,14  and 28 by flow cytometry
After 28days of culture ARPE-19 cell line on with and without glycation
greatly compare with control. For example, in 28 days culture, the means from 
control was only 19.4 but in cells cultured on matrigel fed with POS were 114.25, 
106 (50mM GA), 122 (lOOmM GA), 171 (150mM GA) and 172.25 (200mM GA) 
respectively. The p values are less than 0.001 compare with the day 1 culture.
As we concern that the cell line may not totally represent the true 
characteristics or age-related changes, also as section 2.4.2.1 unfinished work in 
primary cells, the other two primaries RPE cells were achieved and used in our 
experiments by using the same protocol. Results showed the very similar as it 
showed in cell line. See figures 2.24; 2.25; 2.26; 2.27; 2.28; 2.29.
matrigel feeding lx l0 7/ml POS, the auto-fluorescent granules were increased
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Figure 2.24: Primary RPE cells from a 73 year old male were cultured on 
glycated matrigel plates for 2Sdays witout feeding POS. Accumulation o f auto 
fluorescent granules was analysed at day 1, 7,14  and 28 by flow cytometry
M 73 + MGEL & G A (50-200uM ) Feeding  
with 1x10*/m l POS
I P O S  1 X 1 0 6/m l 
I M G E L  + P O S  1X 1 0 6/m l 
l 5 0 m M + P O S  1 X 108/m l
■ 1 0 0 m M + P O S 1 X 1  O’ /m l
■ 1 5 0 m M + P O S  1X 106/ml
■ 2 0 0 m M + P O S 1 X 1 0 “/ml
Figure 2.25: Primary RPE cells from a 73 year old male were cultured on glycated 
matrigel plates for 28days with feeding POS lx l  (f/ml every 48hours. Accumulation 
of auto fluorescent granules was analysed at day 1, 7,14 and 28 by flow cytometry
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Figure 2.26: Primary RPE cells from a 73 year old male were cultured on 
glycated matrigel plates for 28days with feeding POS lx l0 7/ml every 48hours. 
Accumulation of auto fluorescent granules was analysed at day 1, 7, 14 and 28 
by flow cytometry
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Figure 2.27: Primary RPE cells from a 69 year old female were cultured on 
glycated matrigel plates for 28days without feeding POS. Accumulation o f auto 
fluorescent granules was analysed at day / ,  7 ,14 and 28 by flow cytometry
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Figure 2.28: Primary RPE cells from a 69 year oldfemale were cultured on glycated 
matrigel plates for 28days with feeding POS lx l  (f/ml every 48hours. Accumulation 
of auto fluorescent granules was analysed at day 1, 7,14  and 28 by flow cytometry
F 6 9  ♦ M G E L  & G A ( 5 0 - 2 0 0 u M )  F e e d i n g  w i t h  1 i 1 0 7f m I P O S
I P O  S 1 X1 0 7 / m  I 
M G E L  + P O S 1 X 1  0  7 / m  I 
I 5 0 m  M + P O  S 1  X1 0 7 / m  I 
I 1 O O m M + P O  S 1  X 1 0  7 / m  I
■ l 5 0 m M  + P O 8  1 X 1 0  7 / m I
■ 2 0 0 m  M + P O S 1 X 1 0  7 / m I
I
J  2  5 0  -
Day
Figure 2.29: Primary RPE cells from a 69 year oldfemale were cultured on glycated 
matrigel plates for 28days with feeding POS lx l0 7/ml every 48hours. Accumulation 
of auto fluorescent granules was analysed at day I, 7,14  and day by flow cytometry
Unfortunately, at the time of the experiment, cells from young donors 
were not available, so we cannot address whether these changes will happen in 
younger people; further experiments will be done if it is possible to have cells in 
the future.
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2A.3.2 Light/fluorescence microscopy and photography
Figure 2.30: Confluent ARPE-19 Cells cultured on matrigel (without glycation) 
I day without feeding with POS. Magnification x20
Figure 2.31: ARPE-19 Cells cultured on matrigel (without glycation) 14 days 
without feeding with POS. A large number o f dark granules accumulated in 
cytoplasm in RPE and cell death happened. Magnification x20
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Figure 2.32: ARPE-19 Cells cultured on glycated matrigel (200uM) 1 day after 
feeding with lx l( f  /ml POS. Dark granules accumulated in cytoplasm in the RPE. 
Magnification x20
Figure 2.33: ARPE-19 Cells cultured on glycated matrigel (200uM) 14 days after feeding 
with IxUf/mL A large number of dark granules accumulated in cytoplasm in the RPE and 
cell death occurred. Magnification x20
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Figure 2.34: ARPE-19 Cells cultured on glycated matrigel (200uM) I day after feeding 
with lx l0 7/m i Dark granules accumulated in cytoplasm in the RPE. Magnification x20
Figure 2.35: ARPE-19 Cells cultured on glycated matrigel (200uM) 14 days after feeding 
with lx l  0/ml. A large number o f dark granules accumulated in cytoplasm in the RPE and 
most of cells were dead. Magnification x20
Figures 2.30-2.35 The photographs of ARPE-19 cells cultured on 
glycated matrigel (200umM) and matrigel only (figure 3.25) with and without 
feeding with POS (two doses) were taken after 1 and 14 days culture. There was a 
clearly evidence to say that glycation could increase the granules accumulation in
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cells after long periods culture. This support our method that glycated matrigel 
could reflect in vivo conditions. Unfortunately, fluorescent images still could not 
take it under fluorescent microscope (the same reason as before) but the flow 
cytometry results did demonstrate that glycation might have a key role in ageing 
process in human.
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2.5 Discussion
To our knowledge, this study was the first time to examine the AGEs/ALEs 
adducts on human RPE function in vitro. We had investigated the effects of POS 
(low and high doses) and AGEs on the human retinal pigment epithelium cell 
function by using the AREP-19 cell line. Primary isolated human RPE cells were 
also cultured and used in this study to support cell line results.
There were two controls in our study; cells were not given any treatment 
during the culture period, and cells were cultured on “matrigel only” without the 
other treatments. In this study, we used light/fluorescent microscopy and flow 
cytometry to measure whether the AGEs accumulation in RPE with ageing could 
cause cell dysfunction in vitro, which expressed by increase auto-fluorescent in the 
cytoplasm to address our hypothesis.
The significant characteristic of RPE cell ageing was the accumulation of 
autofluorescent granules, which had been addressed it was lipofuscin that could 
cause RPE cells apoptosis and death. Lipofuscin accumulation in the RPE was one 
of the major marks of ageing in the retina. The accumulation o f autofluorescent 
granules in cultured RPE cells had been used as a model to study 
lipofuscinogenesis. Using this model, experiments were designed to distinguish 
between these different substrates and assess their contribution to the fluorophores 
of autofluorescent granules generated in culture.
Our results had demonstrated this effect. Firstly, after cultured ARPE-19 
cell lines 28 days with feeding POS, the auto-fluorescent granules accumulation 
were increased significant comparing with control. The degree was represented by
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the means, for example, in the control group, the increase were only change from 8 
(1 day) to 19.2 (28 days). But after the same time culture feeding with 
P O S lx l07/ml, the means changed from 25 (28 days) in control, to 117.25. It was 
time and POS dose dependent increase. It was also confirmed by using primary 
RPE cells.
It was hypothesised that AGEs, especially when they were immobilised on 
a sub-cellular matrix, could have a significant impact on RPE cell attachment and 
growth dynamics in vitro. Recent evidence suggested that advanced glycation 
made an important pathogenic contribution to this pathology. The AGEs 
accumulation and subsequent protein cross-linking occurred in vivo would be 
expected to decrease the POS indigestion, subsequently increasing lipofuscin 
deposit on RPE in vivo.
In our study, we provided the evidence to demonstrate that AGEs/ALEs 
had a significant role on RPE dysfunction. The results showed that after 28 days 
culture of these cells, especially cells cultured on glycated matrigel, the 
auto-fluorescent granules accumulation increased dramatically compared with 
cells cultured on nonglycated condition.
Overall, these data suggested that the high levels of glycated proteins 
present in cells from diabetics might have deleterious effects on cellular function 
and metabolism in such patients. These data were consistent with the report from 
Boulton (et al., 1998) suggesting that the essential question of whether this 
intervention might come how the AGEs affected the RPE function and led to RPE 
dysfunction with ageing.
Bruch's membrane is known to undergo considerable alteration during
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ageing. It is particularly important that RPE demonstrated the most significant 
changes when cells were propagated on a range of AGE-modified basement 
membrane extract Matrigel®. Because it is known that in vivo, Bruch’s 
membrane is modified by AGE, crosslinking during ageing (Handa et al 1999). 
Thus exposing RPE to an “aged” matrix mimics the in vivo situation.
Significantly, recent studies had demonstrated that this basal lamina 
became thickened (Coffey & Brownstein 1986), crosslinked and heavily 
AGE-modified during ageing (Handa et al. 1999; Farboud et al. 1999; Verijl et al.
1998) had implications with RPE dysfunction and drusen deposition. On the whole 
it was clear that advanced glycation of the sub-cellular matrix was the most 
relevant route for AGE exposure of RPE cells in vitro.
The increase in autofluorescence in cells cultured in medium devoid of 
POS was interesting in our study. Material formation of such autofluorescent 
granules might be derived from autophagy, necrosis/apoptosis of other cells and 
components of the culture medium. As they eat up the matrix if there are lysine 
reactions occurring with free aldehydes intermediates and e.g. lysines in the matrix 
they can be formed so they are called lipofuscin like fluorophores. The variation in 
the amount of autofluorescence accumulating in different passage numbers might 
reflect differences in cell 1) phagocytic ability (Miceli et al., 1994), 2) digestive 
capacity (Boulton et al, 1994; Vilcox, 1988).
Unfortunately, in our light/fluorescent microscope studies,' we could only 
see the differences after 28 days culture RPE cells that there were dark granules 
accumulated in cell cytoplasma under the light microscope. The fluorescent 
images could not be taken under fluorescent microscope to support the results from
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flow cytometry. It may be because the microscope was not good enough or the 
fluorescent granules were not large enough to be seen under those magnificent 
scales as there were only yellow-green background colour could be seen.
In conclusion, this chapter had shown that AGE-modification of the 
matrigel had an important impact on RPE behavior. This was significant because it 
was the most likely route by which RPE would be exposed to AGEs in vivo. 
Overall, within the context of age-related dysfunction of the RPE, it was clear that 
AGEs might have an important role inducing abnormal cell behaviour and 
disruption of normal cell function, which had obvious implications for the 
pathogenesis of many RPE-related disorders.
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3.1 The Effect of AGEs/ALEs on Lysosomal 
Activity in the RPE
3.1.1 Introduction
Lysosomal acid hydrolases are responsible for the degradation of a variety of 
macromolecules such as proteins, lipids, complex carbohydrates, and nucleic acids 
(Berman, 1994) and are much more active in RPE than in many other tissues of the 
body (Hayasaka 1974; Wu and Aguirre, 1997). In the RPE, these enzymes are 
responsible for the degradation of ingested POS materials. It is very important for 
the RPE to maintain healthy photoreceptor-cell function and normal vision. A 
single RPE cell usually can phagocytosis and degrade approximately 2000 -  4000 
outer segment membranous discs everyday (Bok & Young 1969). This can explain 
the main reason why the RPE plays a major role in many age-related diseases of the 
retina. As the lysosomal system is the major system in the retina to phagocytose 
and degrade POS, it has been suggested that the lysosomal contributes to RPE 
dysfunction with ageing leading to increased lipofuscin formation and, perhaps, 
drusen deposition in the sub-RPE space (Hayasaka 1983).
Increasing evidence has suggested that AGEs may have a role in age-related 
RPE dysfunction. It is known that AGEs can be endocytosed by many cell-types, 
and they are directed into secondary lysosomes (Stitt et al 2000). It has been found 
that AGEs accumulated in the lysosomes compartment in other non-retinal cell 
types. Therefore it is reasonable to hypothesise that AGEs have an important 
pathophysiological effect in age-related RPE dysfunction. The research should be 
focused on this complex lysosomal system of the RPE cells and the effects of AGEs
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on the ability of the RPE lysosomal system to degrade photoreceptor outer segments.
Lysosomes can efficiently degrade macromolecules such as proteins and 
lipids at an acidic pH. So far, there are over 60 types of lysosomal enzymes that 
have been found and many of them have been identified in the RPE. The primary 
substrates of the lysosomes in RPE are the protein and phospholipid-rich POS, 
which are degraded by proteases, phospholipases and lipases. The lysosomes of the 
RPE are specialised for breaking down photoreceptor outer segments. Two 
lysosomes, Cathepsin D and acid lipase, are higher in the RPE compared with the 
other ocular tissues (Hayasaka et al 1975). Hayasaka et al 1975) research found 
that the aspartic protease Cathepsin D played a major role in degrading outer 
segments as the Cathepsin D digested the protein rhodopsin which was the main 
glycoprotein component of photoreceptor outer segments (Hayasaka et al 1975).
Cathepsin B is a papain-like cysteine protease, which is one of the major 
components of the lysosomal proteolytic system responsible for protein 
degradation and turnover (Wijffels, 1998; Mort & Buttle, 1997). Cathepsin B has 
been suggested to play a role in growth and metastasis of many types of cancer. 
Movement of Cathepsin B and other lysosomal Cathepsins towards the cell 
membrane or their secretion outside the cell may lead to degradation of the 
extracellular matrix.
Acid phosphatases (APS) are a family of enzymes that are widespread in 
nature. They can be found in human, many animal and plant species. Although they 
have a common functional identify, different kinds of APS are different regarding 
tissue composition; chromosomal origin; molecular weight; amino acid homology; 
sequence length; resistance to L(+) tartrate and to fluoride. Human APS are found at 
low concentrations in physiological condition. However, some significant changes
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in its synthesis can occur in particular diseases; they are expressed either abnormally 
high or low enzyme activity which has been seen as part of the pathophysiological 
procedure. These enzyme activity changes may suggest that APS can be used as a 
method to investigate the pathophysiology of the relative disease related to RPE 
ageing dysfunction in clinic.
The process o f age-related changes of RPE lysosomes enzyme activity is 
unknown. The first report o f an age-dependent reduction in activity of lysosomes in 
the RPE was for a-mannisidase (Wyszynski et al 1989). Similar age-related 
decreases in the specific activities of a-mannosidase, beta- galactosidase 
N-acetyl-beta-glucosaminidase, and N-acetyl beta galactosaminidase have also been 
reported by Cingel in 1996 (Cingle et al 1996). Boulton et al (2001) reported that 
there was an age-dependent decrease in the activities of acid phosphatase and 
Cathepsin D. Verdugo et al (1997) found that the activities of Cathepsin D 
increased with age. Animal research found that ageing rats have been shown to 
accumulate enzymatically inactive but immunological reactive Cathepsin D 
(Wiederanders & Oelke 1984). It seems clear that there are some significant 
changes to the RPE lysosomal system with age.
With the important role to phagocytic and degradation of POS in the RPE, it 
could be expected that any changes in the lysosomes system would lead to its 
dysfunction and would cause a significant consequences for the RPE and retina. 
Advanced glycation has been shown to alter the function of many different proteins 
and to significantly alter the activity of many other enzymes. The free amino 
groups of proteins, such as the c-amino groups of lysine and arginine residues are 
usually the important site for maintaining the protein’s physiological structure and 
function in vivo. Evidence showed these were the primary targets for advanced
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glycation.
Conversely, it has also been shown in some cases that if the primary substrate 
of an enzyme is glycated then it is less susceptible for enzymatic degradation. For 
instance, non-enzymatic glycation of fibrin makes it difficult to be degraded by 
plasmin (Brownlee et al 1983) and glycated fibrinogen is more resistant to 
degradation by trypsin (Krantz et al 1987). After modification by advanced 
glycation, Collagen is hardly digested (Brennan 1989). Similarly, AGE modified 
albumin had less susceptibility to be degraded by lysosomal enzymes of phagocytes; 
degradation was reduced by approximately 40% which caused the accumulation of 
the albumin in the cells (Miyata et al 1997).
AGEs have been shown to inhibit lysosomal enzyme activity in other cell 
types. For example, lung epithelial cells exposed to glyoxal suffered a loss of 
Cathepsin D activity (Kasper et al 1999). Furthermore, the activities of lysosomal 
Cathepsin L, B and H also showed a dose-dependent decrease after exposure to 
AGE-BSA in kidney proximal tubule cells (Sebekova et al 1998). In macrophage 
lysosomes, the degradation of AGE modified LDL is much slower than degradation 
of acetylated or oxidized LDL (Takata et al 1988). Therefore age-related 
accumulation of AGEs in the lysosomal compartment o f the RPE may provide a 
reasonable explanation for some of the changes in the RPE that occur as a function of 
age.
Apart from the possibility to changes in a cells degradative capacity, it is also 
assumed that AGEs may affect phagocytosis of lysosomes because glycation of LDL 
has been shown to reduce cellular uptake by macrophages. This may be due to the 
modification in the e-amino group of lysine, which is important for recognition and 
interaction with the LDL receptor (Lorenzi et al 1984; Gonen et al 1981).
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Considering the function of RPE, it is possible that any disturbance in the cell’s 
phagocytosis function would cause a build up of outer segment-derived materials to 
accumulate either intracellular or within the sub retinal space.
It is a possible to hypothesis that advanced glycation end-products may play 
an important effect on RPE cell dysfunction, mostly through accumulating protein 
and phospholipids-rich POS in lysosomes and causing a deleterious influence on 
degradative ability and lipofuscin formation. The aims of this study were to 
investigate the relationship between the accumulation of AGEs in the RPE and 
lysosomal activity. The activity of several key lysosomal enzymes will be 
evaluated after cells are exposed to AGEs.
Firstly, Cathepsin D was chosen to be a candidate o f lysosomes because it 
was widely regarded as the most important lysosomal enzyme in the RPE. 
However, as it was mentioned before, Cathepsin D would not be the only lysosome 
enzyme which would be affected by AGEs. Therefore another cysteine protease, 
Cathepsin B, was included in this study because previous work had shown that 
inhibition of cysteine protease activity could impair degradation of outer segments 
and led to accumulation of undigested material in the RPE (Rakoczy et al 1994; Katz 
& Shanker 1989). Additionally, acid phosphatase was also included in this study 
according to previous research report.
In the current study a human RPE cell-line (ARPE-19) was used as it retain 
the RPE cell’s phagocytic capacity in culture making it a suitable model to study the 
effects of AGEs on phagocytosis and degradation. Also primary RPE cells from 
different aged donors were also used to testify the results from cell line. Briefly, 
Cells were exposed to the pre-formed glycation matrigel for different time periods 
and enzymes activities were tested by following standard protocols.
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Materials &Methods
3.1.1.1 Cathepsin D  assay
3.1.2.1.1 Sample Preparation
ARPE-19 Cell cultures and POS were prepared as described in section 2.2.1 
and 2.2.2,
Briefly, confluent ARPE-19 cells were detached with trypsin-EDTA in 
75cm culture flasks and resuspened into Ham’s F10 medium (10% FCS + 1% 
antibiotics and fungizone). After mixed well, the cells were transferred into 
6-well plates which were either coated with glycated Matrigel or just plain plastic 
to reach confluence. During culturing time, the medium was changed every 3rd 
day until the cells were confluent. After confluence, the culture medium was 
changed to Ham’s F10 medium (2% FCS + 1% antibiotics and fungi zone) for 24 
hours. The Ham’s F10 medium (2% FCS + 1% antibiotics and fungizone) was 
used continuously until the end of experiments.
POS were diluted with Ham F10 medium (2% FCS + 1 %  antibiotics)
8 9from stock concentration to 1x10 /ml and 1x10 /ml. For a negative control, only 
4 ml of culture medium was added in each well (2 wells). For the lx l0 6/ml
n
sample, 3.96ml o f medium and 40pl of 1x10 //ml were added in each well (2 
wells). For the lx l0 7/ml sample, 3.96ml o f medium and 40pl o f lx l0 9/ml POS 
were added in each well (2 wells). Medium with and without POS were changed 
every 48 hours until the end time point of the experiments (i.e. Day 1, 7, 14 and 
28).
3.1.2.1.2 Cathepsin D Enzyme Assay by using ARPE-19 Cells
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Cathepsin D activity was measured using haemoglobin as substrate with 
modifications to the method according to the protocol described by Boulton et al., 
2001. The principle of this test is to utilize the ability of CAD to digest the 
haemoglobin substrate into Tyrosine. Released Tyrosine was assessed at 570nm 
using a Dias Plate Reader (Dynatech U.S.A). The activity of the CAD was 
quantified with DL- Tyrosine standard curve displayed as pg/ml.
Briefly, after cell cultures reached the time point of experiment, cells were 
washed with PBS twice to remove the medium. Then 250pl of 0.2% Triton X-100 
in 50mM PO4 buffer, pH 7.4, was added to each well and incubated at RT for 15 
minutes to lyses cells. Cells then were scraped using a cell scraper and the lysates 
were transferred into a 1.5ml eppendorf and centrifuged at lOOg for 5minutes. The 
supernatant was collected for measurement.
50pl of 2% haemoglobin in 0.25M Sodium Formate Buffer, pH 3.3, as 
substrate was added to each of 50pl of supernatant and then incubated at 37°C for 
up to 60 minutes. The reaction was stopped by adding 50pi of ice-cold 3% TCA. 
Further centrifugation was done at 1 OOg for 5minutes and the proteolytic products 
from the digested haemoglobin in the supernatant were measured using a standard 
bicinchoninic acid assay kit (Pierce Chemicals, Rockford, IL, USA) which is 
detergent-stable. 25pl of each standard (DL-Tyrosine) and the samples (The 
supernatant) were added into a 96-well micro plate, then 200pl of Work-reagent 
was added to each well and the plate was mixed thoroughly on a plate shaker for 30 
seconds. The plate was covered and incubated at 37°C for 30 minutes and then 
cooled at room temperature. The resulting bicinchoninic acid complex was 
calorimetrically assessed at 570nm using a Dias Plate Reader (Dynatech U.S.A). 
DL-Tyrosine equivalents were used as a calibration curve. Standard curves were
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run at the same time to ensure uniformity of incubation time and substrate 
concentration.
To check the specificity of the assay for aspartic proteinases, pepstatin 
(Sigma) was added in excess (1 -5jLxg/50(nl of cell lysate) half an hour before 
incubation with haemoglobin substrate, and the remaining enzyme activity was 
measured as described above.
D L - T y r o s i n e  s t a n d a r d  c u r v e
2 0
1 . 5
1 .0
0 . 5
0 0 0 2 5 0 5 0 0 7 5 0 1 0 0 0 1 2  5 0
u g / m  I
Figure 3.1 DL-tyrosine standard curve. Absorbencies were measured at 570nm.
3.1.1.2 Cathepsin B enzyme Activity Assay by using ARPE-19 Cells
3.1.1.2.1 Sample Preparation
ARPE-19 Cell cultures and POS were prepared as described in section 2.2.1 
and 2.2.2,
3.1.1.2.2 Cathepsin B Enzyme Assay
This fluorometric assay has been designed for the quantitative in vitro 
determination of CAB activity in micro-plates. The test utilized the ability of CAB 
to digest the synthetic substrate Z-Arg-Arg (AMC). Released free AMC was 
determined fluorometrically at excitation wavelength 355 nm and emission 
wavelength 460 nm. The activity of the CAB was quantified with an AMC standard
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displayed as nmol AMC/mg protein/hour
Basically, ARPE-19 cells were prepared as shown in section 2.2.1 and 
2.2.2. Cathepsin B Substrate, Control Cathepsin B, Calibration Standard, Cathepsin 
B Inhibitor, Reduction Reagent and Assay Buffer were prepared before following 
the protocol. Cell Lyses Buffer, Microtitre Plate and Plate Sealer were provided by 
the kit.
After cell culture reached each time point of the experiment, cells were 
washed with ice-cold PBS twice. Then 500pl of cell lysis buffer was added in the 
flask and incubated on ice for 30 minutes. The lysates were collected into 1.5 ml 
eppendorfs and vortexed for 5 seconds. Then the lysates were centrifuged at 
14,000g in a pre-cooled tabletop micro-centrifuge. After centrifugation, the 
supernatant was immediately transferred to a fresh microcentrifuge tube and the 
pellet was discarded. The lysate was diluted 1:5 before determination of the protein 
concentration via BCA protein assay.
All the reagents were brought to room temperature for assay. 25 pi of the 
activation buffer was pipetted into each well (96 well plate), 50 j l i 1 of standard and 
control Cathepsin B were added into each well (all samples are duplicated). Then 
the plate was pre-incubated at room temperature for 5 minutes. Then, 25 pi of 
substrate solution was added into each well. The plate was sealed tightly and 
incubated at 37°C for 30 minutes. The fluorescence of free AMC was read on a 
fluorescence plate reader at excitation wavelength 355 nm and emission 
wavelength 460nm. The fluorescence measured was converted to nmol AMC using 
the slope of the standard curve (figure3.2)
92
The C riticaLRole o f  A G Es/A LE s in Age-Related Dysfunction o f  the Retinal Pigm ent E p ith e lium Chapter 3
12000
10000
2  8 0 0 0  cD<L>
g  6 0 0 0o
C/5<L>
u .
M 4 0 0 0Uh
2000
0
60 53 42
AMC concentration 
(nmol/mg protein/hour)
Figure 3.2 Standard curve o f Cathepsin B (AMC Standard curve).
3.1.1.3 Acid Phosphotase Enzyme Activity
3.1.1.3.1 Sample Preparation
ARPE-19 Cell cultures and POS were prepared as described in section 2.2.1 
and 2.2.2.
3.1.1.3.2 Enzyme Assay
Cells were lysed with 0.2% Triton X-100 in distilled water for 5 minutes. 
Then the lysates were incubated with 7.5mM /?-nitrophenyl phosphate in 0.1M 
acetate buffer (pH 5.0) for 45 minutes at 37°C. The reaction was stopped by the 
addition of lOOmM NaOH (pH 10.5), and the absorption of light by p-nitrophenol 
released in the reaction was measured at 405nm. By using a calibration curve for 
p-nitrophenol, the absorbance values were converted to picomoles of reaction
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3.2 Results
3.2.1 Cathepsin D Activity
3.2.1.1 Cathepsin D activity in ARPE-19 Cell
A wide range of lysosomal enzymes are present in RPE cells, and they are 
responsible for the continuous digestion of phagocytosed POS in vivo, on the basis o f 
enzymic studies, it has been proposed that the most important enzymes involved in the 
proteolysis of rhodopsin is Cathepsin D. Primary enzymic studies showing increased 
aspartic proteinases activity in RPE cells, which is about five times higher than that in 
liver, have recently been confirmed by Northem-blot analysis demonstration the 
up-regulation of CAD transcription (Rakocay et al., 1997). It has been demonstrated 
by enzymic assay that inhibition of aspartic proteinases results in a significant 
decrease in rhodopsin proteolysis (Rakocay et al., 1997). But, in spite of the CAD’s 
significant role in the normal function of RPE cells, so far, there is very little known 
about the control and activation of CAD in these cells and the consequences of any 
changes that occur in CAD activity.
In this work, Results were shown in figure 3.4 and figure 3.5; these were 
mean averages from 4 independent experiments. Enzyme activities showed a dramatic 
increase after cells were cultured 14 days feeding with POS with and without 
glycation and reached its peak of activity and day 14th. From 14 to 28 days, the 
activities went down quickly, especially for cells challenged with POS compared with 
cells without challenge with POS (p< 0.05). For cells cultured on different glycation 
conditions feeding with POS, Cathepsin D activity changes showed the similar trend 
but had much lower extent than without glycation; they were glycation condition and 
POS dose dependent. There were no significant glycation concentration dependent
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changes observed. Results seen from figure 3.4, there were no difference changes 
among GA concentrations (0-200mM). For example, after 28days culture, the enzyme 
activity was 0.069pg/l05cells/min in cell cultured on lOOmM GA fed with lx l0 7/ml 
POS, and the control was 0.183pg/l 05cells/min in control. It was about 64% decrease)
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Figure 3.4 Cathepsin D activities were measured after cells exposed with and 
without glycation, feeding with and without POS for 28days. The changes were significant 
with depending on the POS dose, glycation condition and time changes. There was no 
glycation concentration dependent change (a: Matrigel only; b: 50mM GA; c: ISOmM GA 
and d: 200mM GA feeding with POS [Two doses]).
96
The Critical Role o f  AGEs/ALEs in Age-Related D ysfunction o f  the Retinal Pigm ent Epithelium Chapter 3
Cathepsin D activity in A R PE-19 cells
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Figure 3.5 Cathepsin D activity was measured after cells exposure to glycation 
with and without feeding POS. (p<0.001 in cells cultured on lOOmM GA fed  with 
lx l  0'/ml at 28days compare with control)
3.2.1.2 Cathepsin D activity in Primary RPE Cells
As mentioned previously, primary RPE cells were also used in our 
experiments. Figure 3.6-3.10 showed the RPE cells isolated from a 73 year-old male 
and a 69 year-old female (results not show as they showed the similar) donors and 
Cathepsin D activities were measured as in section 3.2.1.1. The Cathepsin D activity 
changes were time, POS doses and glycation condition dependent but not glycation 
concentration dependent.
97
The Critical Role o f  AGEs/ALEs in Age-Related Dysfunction o f  the Retinal Pigm ent Epithelium Chapter 3
M 73  C a t h e p s i n  D A c t i v i t y  ( w i t h  a n d  w i t h o u t  M g e l )
” * • -  R O S  1 0  ®/m I 
— R O S  1 0 7/ ml  
■ ♦  m g e l  O n l y
M G E L  + P O S  1 X 1  0®/ ml  
" O —  M G E L  + P O S  1 X 1 0 7/ ML
0. 5-1
c
E 0 . 4 -  tJJ
o
0)c
%
£
o.o o 7 2 11 4 28
D a y
Figure 3.6 Cathepsin D activities was measured after primary RPE cells from a 
73 year-old male were exposed with and without glycation, feeding with and without POS 
for 28days. There were POS dose, glycation condition and time dependent changes but 
there was no glycation concentrations dependent change. (P=0.0014 in cells cultured on 
matrigel only fed  with lx l0 7/ml POS at 28days compare with control)
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Figure 3. 7  Cathepsin D activities was measured after primary RPE cells from a 73 
year-old male were exposed with and without glycation, feeding with and without POS for 
28days.(p=0.0017 in cells cultured on SOmM GA fed with lx l0 7/ml POS at 28days 
compare with control)
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Figure 3.8 Cathepsin D activities was measured after primary RPE cells from a 
73 year-old male were exposed with and without glycation, feeding with and without POS 
for 28days.(p<0.001 in cells cultured on lOOmM GA fed  with lxlO'/ml at 28days compare 
with control)
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Figure 3.9 Cathepsin D activities was measured after primary RPE cells from a 
73 year-old male were exposed with and without glycation, feeding with and without POS 
for 28days. (p<0.001 in cells cultured on ISOmM GA fed  with lx l0 7/ml at 28days compare 
with control)
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Figure 3.10 Cathepsin D activities was measured after primary RPE cells from a 
73 year-old male were exposed, with and without glycation, feeding with and without POS 
for 28days. (p=0.0019 in cells cultured on 200mM GA fed  with lx l  0'/ml at 28days 
compare with control)
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3.2.2 Cathepsin B Activity
Rakoczy et al (1994) reported that inhibition of cysteine protease activity 
impaired the RPE capability to degrade POS and caused lipofuscin like material 
accumulation. Therefore we included Cathepsin B activity examination in our study 
and it was measured under the same conditions as the Cathepsin D assay using only 
ARPE-19 cells. Results are showed in figure 3.11-3.13; results are mean averages 
from 4 independent experiments. Cells were exposed for 28 days, with and without 
glycation feeding and with and without POS; there were time, glycation condition 
and POS dose dependant changes but not glycation concentrations dependent 
changes. (p=0.023 in matrigel only fed with lx l0 7/ml POS compare with control; 
p<0.001 in 50mM GA fed with lx l0 7/ml POS compare with control)
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Figure 3.11 Effects o f  AGEs on Cathepsin B activity. Cathepsin B activity was 
measured after cells fed  with and without POS for 28days.
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Figure 3.12 Effects o f AGEs on Cathepsin B activity. Cathepsin B activity was 
measured after cells exposed to matrigel fed  with and without POS for 28days.((p=0.023 
in matrigel only fed  with lx l0 7/m l POS compare with control)
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Figure 3.13 Effects o f AGEs on Cathepsin B activity. Cathepsin B activity was 
measured after cells exposed to glycation fed  with and without POS fo r  28days. (p<0.001 
in cells cultured on SOmM GA fed  with lx l  O'/ml at 28days compare with control)
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3.2.3 Acid Phosphatase Activity
The effects o f AGEs on Acid Phosphatase Activity were measured following 
the protocol from Boulton et al (2001). Cells were treated the same as in section
2.2.1 and 2.2.2. Results are showed in figure 3.14 and were mean averages from 4 
independent experiments. Generally, there were increases of enzyme activities after 
cells exposed with and without glycation without feeding POS; however, when cells 
were exposed to glycation and fed 28 days with POS, there was a significant 
decrease (p<0.05) of enzyme activity observed and they were time, GA condition 
and POS dose dependent. There were no significant glycation concentrations 
dependent changes observed in our experiments (results are not shown)
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Figure 3.14 Effects o f AGEs on Acid Phosphatase Activity
3.2.4 statistical Analysis
Results are expressed as mean and standard deviation which were calculated 
using Prism software. Statistical significance between treatments and controls were
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evaluated by the one-way ANOVA (and nonparametric) unpaired t Test. A p value 
of less than 0.05 was considered significant.
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3.3 Discussion
To what extent AGEs contribute to changes of lysosomal enzyme activity in 
age RPE is unclear. Many conflicting reports have shown there was both an 
age-related increase and decrease of lysosomal enzyme activity in vitro with data 
showing differences between species, the type of tissue analyzed and the 
methodology. In general; studies indicate an increase in lysosomal enzyme activity 
with age in the RPE. (Stitt et al., 1999) This apparent contradiction of our data can be 
explained by the steady accumulation of lipofuscin granules with age.
Accumulation of Lipofuscin in RPE cells is the most significant change in 
the aging process. Due to the RPE having a very high degradative load everyday, 
even just a small change in enzyme activity would have severe consequences for the 
RPE and photoreceptors. It was hypothesised that the deposition o f AGEs in RPE 
cells could have deleterious effects on the specialised lysosomal enzymes system 
degradation capability. It we could prove this, it would have obvious implications to 
explain the formation of lipofuscin in aged RPE. Evidence has shown that 
accumulation of AGEs in the lysosomes could reduce the RPE capacity to degrade 
photoreceptor outer segments, resulting in the accelerated accumulation of 
lipofuscin granules in the RPE cytoplasm.
Kasper et al {1996, 1999) reported that AGEs accumulation in the lung 
epithelial cells caused damage to the normal cell functions and renal tubular 
epithelium cell function as well (Gugliucci & Bendayan 1996). However, in 
Rakocyz’s (et al 1999) report that there was no impaired Cathepsin D expression by 
AGE treatment and also there was no down-regulated Cathepsin D in the aged 
patients with AMD. In our study it has been shown that AGEs had a remarkable
105
effect on Cathepsin D activity. This is significant because the primary function of the 
RPE is to phagocytose and degrade ROS, and Cathepsin D has been widely 
considered as the most important protease in the RPE (Regan et al. 1980). 
Furthermore, this enzyme has already been implicated in age-related dysfunction 
(Boulton et al 1994).
Kasper et al have also recently demonstrated that AGEs could mediate 
dysfunction of Cathepsin D activity in lung epithelium (Kasper et al 1999) and 
Sebkova demonstrated that AGEs could impair protein degradation in kidney 
epithelial cells (Sebkova et al 1998). However, the association is not fully elucidated 
between abnormalities in RPE lysosomal function and AMD, even though it could 
be speculated that RPE cell’s function could be impaired by the degratative enzymes 
which would lead to degeneration o f the overlying POS. Due to the heavily load of 
work on the RPE and the fact that these cells must carry out this degradation job for 
a lifetime, even just a small changes of the enzyme activity in the cells would have 
a severe consequences for the RPE and photoreceptors.
This enzyme has already been implicated in age-related dysfunction 
(Boulton et al 1994; Verdugo et al 1997). In our study it is also shown that AGEs 
have a remarkable effect on decreasing Cathepsin D activity and it is significant. 
There was a significant increase in Cathepsin B activities in our results and it is 
contradictory to Sebekova’s et al report in 1998; they found Cathepsin B had a AGEs 
dose-dependent reduced proteolytic activity after exposure of kidney epithelial cells 
to AGE-albumin. This maybe because the different local sites o f glycation or the 
residues which are most susceptible to glycation are positioned differently between 
these two enzymes that account for the different enzyme activities o f Cathepsin B 
and D after exposure to AGEs. Further investigation should be done in the future.
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The mechanisms of advanced glycation causing the observed dysfunction of 
enzyme could be due to either the enzyme active site residue being modified directly 
by Maillard chemistry and/or through secondary reaction with AGE-modified 
proteins phagocytised by lysosomal enzymes. Other studies in other proteins have 
found similar results that oxidised LDL can deactivate lysosomal proteases through 
forming covalent linkages with residues in the active site (Hoppe et al 1994). 
Furthermore, non-enzymatic glycation proteins from lens crystalline (Liang & 
Chylack 1984) and serum albumin (Shaklai et al 1984) have altered tertiary structure 
and function, while posttranslational modification of basic fibroblast growth factor 
by advanced glycation causes reduced activity (Giardino et al 1994). It is possible 
that the glycation in the local site of these three enzymes, Cathepsin D, Cathepsin B 
and acid phosphatase enzyme, are different and this could account for the different 
enzyme activity expression among of them which after exposed to AGEs.
Taken together, all these results may suggest that AGEs could have some 
influence on retinal pigment epithelial cell dysfunction through accumulation of 
components in the lysosomal, modifying enzymatic function and perhaps leading to 
abnormal degradative capacity. Further studies o f the exact mechanism of the 
changes inside the lysosomes should be required to fully investigate this potentially 
important phenomenon.
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4.1 Identification of Gene Expression of 
ARPE-19 Cells Exposed to AGEs/ALEs by 
Using RT-PCR
4.1.1 Introduction
As mentioned previously, advanced glycation end products have been 
implicated in a variety o f age-related diseases, for example: Alzheimer’s disease, 
cataract, and atherosclerosis. In J. T. Handa’s (et al 1999) report, they quantified 
that there was an age-dependent increase in AGEs in human Bruch’s membranes; 
the AGEs were identified in basal deposits and Drusen. In 2001, they also reported 
that AGEs altered mRNA phenotype in the ARPE-19 cells which induced by 
culturing the cells on growth factor reduced matrigel modified by AGEs (J.T. 
Handa et al 2001). The altered expressed gene clusters were included those 
involved in cell differentiation, maintenance of the basement membrane, and early 
apoptosis. These genes were previously not known to regulate by AGEs expressed 
in the RPE cells.
From their results, we hypothesize that AGEs may also induce ageing 
mRNA phenotypes in the RPE that would promote either up or down-regulation of 
gene expressions related to Cathepsin B, Cathepsin D and Acid Phosphatase genes 
in the RPE cells to match our previous experimental results. Initially, to address our 
hypothesis, we used the Real-time RT-PCR method to evaluate the gene expression 
of Cathepsin D, Cathepsin B and Acid Phosphatase gene expression after the 
APRE-19 cells were treated with and without glycation conditions in different time
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scales feeding various concentrations of POS as in our previous study.
Real time RT-PCR is carried out by using the Lightcycler™ (Roche) system 
which is specialised to quantify gene expression. Many advantages have been 
found by using Real time RT-PCR. It includes greater specificity, sensitivity and 
speed. However the most significant advantage is that the results are quantitative. 
For example, using the Lightcycler system to quantify PCR, the reaction can be 
completed in less than 30 minutes. As Real-time PCR can constantly detect the 
product formation during the reaction, it will allow the products to be analysed at 
the optimal point. The conventional PCR can only analysis the end-point of the 
reaction (semi-quantitative).
The mechanism of The Lightcycler™ (Roche) is a micro-volume 
fluorimeter integrated with a rapid thermal cycler (Wittwer et al 1997a). It can 
continuously monitor the double strand specific dye SYBR green I, which allows 
us to analyze the PCR reaction in real time, and at the same time the product 
amplification is still in progress. Rapid thermal cycling is achieved by using air as 
the temperature transfer medium and the reaction is carried out in glass capillaries 
with a high surface to volume ratio (Wittwer et al 1997a). This quantitative PCR 
can be completed in less than 30 minutes due to these rapid thermal cycling 
properties (Wittwer et al 1997a). SYBR Green I have a special character; when it is 
unbound, the fluorescence level is very low but after binding to double stranded 
DNA, it will have a very strong fluorescence and can be measured after each cycle 
of product extension. Therefore, as the cycle numbers increase, the fluorescence 
increases. When it is denaturising, the dyed molecules are released and the 
fluorescence signal decreases.
The advantage of detecting products by using SYBR Green I is that there is
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no sequence specificity. This will make it easier when adapting primers used for 
conventional PCR when used with the Lightcycler system (Morrison et al 1998). 
However, as it has no sequence specificity, the SYBR Green I will bind to any 
double stranded DNA which means the other non-specific double strand products 
will also be detected during the reaction, such as primer dimers. In order to 
overcome this problem, the fluorescence is measured at a temperature which is just 
below the product melting temperature (Tm) instead of at the elongation 
temperature to increase the sensitivity because only specific products are double 
stranded at this temperature point. Therefore it can eliminate detection of shorter, 
non-specific products such as primer dimers (Morrison et al 1998). The use of 
SYBR Green I for product detection has recently been successfully applied to 
measure retinal mRNA phenotype changes in the ARPE-19 cells which is induced 
by advanced glycation products (J.T.Handa et al., 2001)
In addition to the advantages of rapid thermal cycling properties, the 
Lightcycler also has the distinct advantage of product amplification and analysis 
which can occur at the same time. This is in contrast with conventional PCR, where 
product analysis is usually carried out separately from product amplification by 
agarose gel electrophoresis and visualisation using dyes such as ethidium bromide. 
However, the Lightcycler uses DNA melt curve analysis for product differentiation. 
The basis for melt curve analysis of PCR is the fact that each specific 
double-stranded DNA (dsDNA) has a specific melting temperature. The melting 
temperature is defined as the temperature at which 50% of the DNA is denatured and 
is determined by the product length and GC content.
The melt curve of DNA is generated by plotting fluorescence as a function of 
temperature, whilst the Lightcycler heats through the dissociation curve (Ririe et al
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1997). The basic principle is that when the temperature increases, the fluorescence 
intensity gradually decreases until there is a sharp loss of fluorescence while the 
product is denatured, which means that a specific product melts at this temperature. 
The advantage of Lightcycler compared with Gel electrophoresis is that the melt 
curve analysis can distinguish different products with the same length but at 
different GC/AT ratio. For example, primer dimers or other non-specific 
amplification products can be seen to melt at lower temperatures in broader peaks. 
Due to its ability to tightly control temperature, the Lightcycler can precisely 
distinguish different PCR products based on their highly specific melting 
temperature. It can discriminate PCR products from each other that differ even 
within 2°C (Ririe et al 1997).
I l l
4.1.2 Materials & Methods
4.1.2.1 Sample Preparation
ARPE-19 Cell cultures and POS were prepared as described in section 2.2.1 
and 2.2.2,
Briefly, confluent ARPE-19 cells were detached with trypsin-EDTA in 
75cm culture flasks and resuspened into Ham’s F10 medium (10% FCS + 1% 
antibiotics and fungizone). After mixed well, the cells were transferred into 6-well 
plates which were either coated with glycated Matrigel or just plain plastic to reach 
confluence. During culturing time, the medium was changed every 3rd day until the 
cells were confluent. After confluence, the culture medium was changed to Ham’s 
F10 medium (2% FCS + 1% antibiotics and fungi zone) for 24 hours. The Ham’s 
F10 medium (2% FCS + 1% antibiotics and fungizone) was used continuously until 
the end of experiments.
POS were diluted with Ham F10 medium (2% FCS + 1% antibiotics) from
D Q
stock concentration to 1x10 /ml and 1x10 /ml. For a negative control, only 4 ml of 
culture medium was added in each well (2 wells). For lx l0 6/ml, 3.96ml of medium 
and 40pl of lx l0 8/ml were added in each well (2wells). For lx l0 7/ml, 3.96ml of 
medium and 40pl of lx l0 9/ml POS were added in each well (2wells). Medium with 
and without POS were changed every 48 hours until the end time point of the 
experiments (i.e. Day 1, 7, 14 and 28).
4.1.2.2 Total RNA Isolation
Total RNA was isolated with TRIzol reagent from all conditional 
treatments of ARPE-19 cell type using the manufacturer’s protocol (Gibco BRL, 
Life technologies, UK). Briefly, the cells were lysed by adding 0.5ml of TRIzol
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reagent to the monolayer and a cell scraper were used to detach the cells. The cells 
then were incubated for 5 minutes at room temperature to allow the complete 
dissociation of nucleoprotein complexes. 0.2ml of Chloroform was added to the 
solution, vortexed and incubated at room temperature for 3 minutes. The mixture 
was separated by centrifugation at 12000g for 15min at 4°C. Following 
centrifugation, the solution forms three phases; the lower red phenol-chloroform 
phase contained proteins; the middle phase contained DNA and the upper aqueous 
phase contained the RNA. The aqueous phase was transferred to a fresh 0.5ml 
eppendorf tube and the RNA precipitated by mixing with isopropyl alcohol; the 
samples were centrifuged at 12000g for lOmin at 4°C. At this point, the RNA pellet 
was washed with 75% ethanol and the sample was vortexed and centrifuged at 
7500g for 5min at 4°C. The pellet was air dried for approx 5-10min and the RNA 
pellets were dissolved in 1 OOpl o f DEPC-treated water. The concentrations and 
purity o f the RNA were determined by ultraviolet spectroscopy and by UV 
visualization on a denaturing formaldehyde-agarose gel. The newly extracted RNA 
was used immediately for RT-PCR analysis or frozen at -80°C.
4.1.2.3 Purity testing o f Total RNA: Formaldehyde-Agarose Gel Electrophoresis 
and UV Transillumination
The overall qualities o f the RNA samples were assessed via electrophoresis 
on a denaturing formaldehyde-agarose gel. The gel was prepared by dissolving 1% 
agarose in DEPC water and once cooled to 60°C, 0.01% of ethidium bromide 
(lOmg/ml), Mops buffer (final concentrations of Mops 0.04M Mops, pH 7.0, 0.01M 
Sodium Acetate, 0.001 M EDTA) and 37% formaldehyde (final concentration 6.6%) 
were added. The RNA (lpg ) was denatured by heating at 60°C for 5min and then
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mixed with loading dye (Promega, UK) in a 6:1 ratio. The RNA was electrophoresed 
using a Mops running buffer at 60V for 45min. After electrophoresis, the gel was 
visualized and digitally photographed on a UV transilluminator (UVi Tec, UK).
4.1.2.4 RT-PCR Amplification of Glycated RNA
Total RNA was used to synthesize cDNA using the manufacturer’s protocol 
provided with a Reverse-iT™ 1st Strand Synthesis Kit (AB gene, UK) and 
performed in a thermo-cycler (DNA Engine, DYID, UK). Briefly, total RNA (1 pig) 
was initially heated at 70°C for 5min in the presence of 1 pi of anchored oligo dT 
(500ng); DEPC-treated water was added to give a total reaction volume of 13pi. 
The first strand cDNA synthesis reaction was performed in 40pl reactions 
composed of 4pl of first strand synthesis buffer, 2pl of dNTP mix (5mM) and lp l 
of Reverse-iT RTase. The reaction was incubated at 47°C for 30min and terminated 
at 75°C for lOmin. The newly synthesized cDNA were used immediately for PCR 
analysis/frozen at -20°C.
4.1.2.5 PCR Amplification of Glycated cDNA
PCR amplification of the cDNA were performed in a DNA thermal cycler 
(DNA Engine, DYID, UK). The PCR reaction mixture contained lx  PCR buffer 
(50mM Tris-HCL (pH 8.0)), lOOmM NaCl, 0.1 mM EDTA, ImM DTT, 50% 
glycerol and 1% Triton X-100, MgCl2 , lOOpM dNTPs, lOOpM primers and 
0.025U/pl Taq polymerase in a final volume of 40pl (all PCR reagents were 
purchased from Promega, UK). The primer pairs for the investigate gene fragments 
were shown in table 4.1.1 and were synthesized based on human sequences 
obtained from Genebank. Glyceraldehydes 3-phosphate dehydrogenase (GAPDH),
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assession number; BC023632. Acid phosphatase (APS), assession 
number;BT019589, Cathepsin B (CAB); assession number; NM147783), 
Cathepsin D (CAD); assession number BT020155.
All PCR primers were synthesized by MWG-Biotech, Germany. Table 4.1.1 
showed the primer sequences, the accession numbers and optimized thermal 
cycling conditions used in these PCR amplification reactions. Negative controls of 
cDNA synthesis were carried out under the same experimental conditions, but in 
the absence o f reverse transcriptase.
Table 4.1 PCR Primers and Parameters used for mRNA Quantity
Gene
Product
Sequence PCR Parameters M gCl2
(mM)
GAPDH
(BC023632)
5 -T G  A T G  AC A TC  A A G  A A G G T G C T G  AA-3 (sense) 
5 -T C C T T G G A G G C C A T G T G G G C C C A T -3 '(an tisen se)
75°C, 30s; 94°C, 2m in; (94°C, 20s; 56°C, 
30s; 72°C, 30s);
72°C, 5min (35 cycles)
1.5
APS
(BT019589)
5-' GA C A G C  A A A G T C C  A G G  A A G C -3 (sense)
5-' G T G G TC T G  A T A C G C G  A G  A C A -3 ' (antisense)
75°C, 30s; 94°C, 2m in; (94°C, 20s; 56°C, 
30s; 72°C, 30s);
72°C, 5m in (35 cycles)
1.5
CAB
(NM147783)
5-' A G A A T G G C A C A C C C T A C T G G -3 (sense) 
5 -' TG C  A T T T C T A C C C C G  A T C T C -3 ' (antisense)
75°C, 30s; 94°C, 2m in; (94°C, 20s; 56°C, 
30s; 72°C, 30s);
72°C, 5m in (35 cycles)
2.0
CAD
(BT020155)
5-' G A C A C  A G G C  A C T T C C C T C  A T -3 ' (sense)
5-' G G  A C  A G C T T  G T A G C C T T T  G C -3 ' (antisense)
75°C, 30s; 94°C, 2m in; (94°C, 20s; 56°C, 
30s; 72°C, 30s);
72°C, 5m in (35 cycles)
2.0
4.1.2.6 Optimization o f Magnesium Concentrations and Annealing Temperatures for 
PCR Products
To ensure the successful amplification of the glycated gene fragments the 
optimum magnesium concentrations and annealing temperatures were determined. 
Firstly, the concentrations of MgCb were investigated in increasing 0.5mM 
increments o f 1 .OmM, 1.5mM and 2.0mM. In parallel, the amplification of the
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house keeping gene (GAPDH) at each MgCk concentration was studied at the 
annealing temperatures of 50°C, 53°C and 56°C. The amplification of the 
lysosomal primer sets (APS, CAB and CAD) were optimized. The PCR and 
agarose gel electrophoresis were carried out as previously described. After 
visualization of the PCR products by means of UV trans-illumination the most 
robust amplification conditions were chosen for subsequent PCR studies.
4.1.2.7 Determination o f Linear PCR Conditions
The linearity o f the PCR reaction for all glycated gene fragments was 
established to ensure quantitative conditions. The RNA extraction and RT-PCR 
were carried out as previously described. The amount o f PCR product was 
determined during increasing PCR cycle numbers in 3 cycle increments of 23, 26, 
29, 31, 33 and 35. Following the PCR reaction agarose gel electrophoresis was 
performed and the gels analysed as previously described. The PCR cycle data were 
expressed graphically as the percentage increase in PCR product compared to 0 
cycles at each cycle number. From the graphical plot a cycle number was 
determined which was in the linear range o f the PCR reaction and therefore suitable 
for the subsequent lysosomal enzyme expression studies.
4.1.2.8 Real Time RT-PCR
The cDNA was amplified in a PCR utilising sequence-specific primers for 
the genes of interest (table 4.1). cDNA samples were diluted 1/10 and the reactions 
were performed in triplicate. The cDNA (2jli1) was mixed with 0.5pM 
sequence-specific primers, 4mM M gCb and Lightcycler Master Mix (Biogene), 
which contained deoxynucleotides and Taq DNA polymerise in reaction buffer so
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that the final volume was 20pl.
The PCR reaction was performed in the Lightcycler (Roche Diagnostics Ltd, 
Lewes, UK). After an initial denaturising step at 95°C for 30 seconds, this was 
followed by 35 PCR cycles o f denaturation at 95°C, then a primer-dependent 
annealing temperature for 3-5 seconds followed by elongation at 72°C for 4-9 
seconds. The elongation period was determined by product length, with 1 second 
incubation for every 25bp o f the product. Fluorescence was measured once per 
cycle after the product extension phase. For negative controls, one reaction was set 
up with the cDNA absent from the reaction mixture and a second negative control 
consisted of a cDNA sample that had undergone the reverse transcription reaction, 
but had the RT omitted (no RT control). In each series o f PCR reactions, the 
standards used were dilutions o f one of the samples (1:10, 1:25, 1:50, 1 TOO).
The product melting curves were obtained immediately after the PCR 
reaction by cooling the sample to 62°C, and then increasing the temperature slowly 
at increments of 1°C per second to 95°C whilst monitoring the fluorescence 
continually. To verify the specificity o f the melt curve analysis PCR products were 
subsequently subjected to agarose gel electrophoresis, stained with ethidium 
bromide (10 pg/ml) and visualised on a TFX-20M UV Transilluminator (Gibco) 
connected to a digital camera (Kodak digital science).
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4.2 R esults
4.2.1 RNA Analysis
The purity of the RNA was tested by using agarose gel electrophoresis 
and it showed specific bands of ribosomal RNA. They were clearly visible and 
corresponded to the highly abundant 18S and 28S total ribosomal RNA. The 
integrity of these bands reflects the integrity of the mRNA. As both bands were 
sharp and clear without smearing, this indicated that the sample degradation was 
minimal. This was shown in Figure 4.1.
18 S
Figure 4.1 total RNA shows in agarose gel electrophoresis
Gel shows two 18s and 28s RNA bands, it indicates good quality o f  total RNA isolation for 
all samples as there was no smearing in the bands.
4.2.2 RT-PCR
The Lightcycler™ can provide two part of analysis o f the data. One is
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quantification and the other one is product analysis by DNA melting curves.
4.2.2.1 Product Analysis by DNA melt curves
The amplification reactions analysed by the melting curve showed a 
gradually deduction in fluorescence when the temperature was increased (Figure
4.2).
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Figure 4.2 Melt curve analysis Cathepsin D gene expression by lightcycler.
When the product was denatured, the sharp drop in fluorescence occured which 
indicated the presence o f a specific product that melted at this temperature. The 
fluorescence drop could also be seen more clearly as a peak in a first negative 
derivative plot (Figure 4.2b). This plot of the negative derivative of fluorescence 
with respect to temperature versus temperature (-dF/dT) produced melting peaks
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rather than of a sharp fluorescence decrease (Figure 4.2b). This was also confirmed 
by agarose gel. For each primer pair used the presence of a single product was 
confirmed by identification of a single band at the predicted size by agarose gel 
electrophoresis. Figure 4.3 showed the presence of a single band at the correct size 
for the Cathepsin B, Cathepsin D and acid Phosphatase components.
1000BP
GAPDH APS CAB CAD
Figure 4.3 Agarose gel electrophoresis showed the presence o f a single band at the correct 
size for the GAPDH (240bps), Acid Phosphatase (195bps), Cathepsin B (212bps), and 
Cathepsin D (168bps) component.
The melt curve analysis of each of the gene of Cathepsin B, Acid Phosphatase 
components and GAPDH had a single sharp peak indicating the presence of a 
specific product (Figure 4.4). Primer dimers can be seen to melt at lower 
temperatures and form broader peaks (Figure 4.4).
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Figure 4.4 the melt curves for Cathepsin B (A), D (B), Acid Phosphatase(C) and GAPDH (D) 
house keeping genes.
121
ThcCYitic a lR o lc,_Ql^^G l,sA L l:^ jn  A&c-RclaicdD yslunclion ,Q fthc R c tin al _ Pi gm c n t I;p  i t h c) i u m _ .. Chapter, 4
4.2.2.2 Quantification
Figure 4.5 showed the light cycler quantification graphs. The exponential 
phase of the amplification reaction was identified as the "log-linear" portion in the 
plots of log fluorescence against cycle number (Figure 4.5a). A threshold level of the 
fluorescence from each amplification reaction was set in the log-linear region. The 
standard curve was created by using a control cDNA dilution series. The 
fluorescence signal cycle number crosses this threshold level was plotted against the 
log of the template concentration (Figure 4.5b) and this was used to define the 
relationship between template concentration and the cycle number where product 
amplification entered the log-linear region. Because the cycle number which the 
level of fluorescence raised above a background threshold value was inversely 
proportional to the long of the initial number of template copies, the relative 
concentration of message in each sample could then be derived from this standard 
curve (Figure 4.5b).
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Figure 4.5 lighecycler Quantification of Cathepsin D gene expression
Photograph A showed logarithmic plot o f fluorescence (FI) against cycle number. B 
showed the cycle number at which fluorescence crossed a threshold level was plotted against the 
log o f  known template concentration to produce a standard curve. The concentration o f an 
unknown sample could be derived from its crossing point.
4.2.2.3 Results Data Analysis
The quantification and analysis o f the product data was analysed by using the 
Lightcycler™ software. The fluorescence was measured once per cycle and it was 
displayed in real-time immediately after each measurement in a plot of fluorescence 
against cycle number, which was updated after each thermal cycle. For
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quantification of data, the baseline of all reactions was first equalised and the 
background fluorescence was then removed by setting a noise band on the plot of log 
fluorescence against cycle number. The cycle number at which the log linear 
portion of each amplification curve intersected the noise band was inversely 
proportional to the log of the copy number (Figure 4.5) and relative expression in 
each sample was calculated from this graph.
4.2.2.4 mRNA Expression in RPE After Exposure to AGE Modified Matrigel.
Real-time PCR was used to quantify levels of Cathepsin B, Cathepsin D, 
and Acid Phosphatase gene expression after exposure ARPE-19 cells to AGEs 
immobilised basement membrane extract (matrigel). mRNA expression levels of 
each of enzymes were shown in figure 4.6, expression levels of GAPDH RNA were 
also assessed and the mRNA levels of the individual components was then 
normalised to the values obtained for GAPDH. As a house keeping gene of GAPDH, 
it did not change by any circumstance, for example, the cells were with or without 
glycation during the experiments, the gene expression were expressed at the same 
levels from beginning to the end of experiments. This allowed it to be used for 
normalising the other genes’ expression results.
To allow analysis of gene expression between separate runs values were 
expressed as a percentage relative to normal. Statistical analysis was performed 
between the results obtained from the normal RPE cell by using a paired Student’s 
t-test (2-tailed).
Results showed after 28 days cultures of ARPE-19 cells on glycated 
matrigel. the gene expressions o f Cathepsin D, Cathepsin B and Acid Phosphatase of 
the cells were up and down regulated by AGEs treatment compared with the
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non-glycated treatment, which supported our results in chapter 3. Results showed in 
figure 4.6. for example, Cathepsin D activities were decreased 95.7% in cells 
cultured on 150mM GA matrigel fed with lx l0 7/ml POS compare with control; 
Cathepsin B activities were increased 984 folds, APS was increased 7.08 fold in the 
same conditions compared with Cathepsin D respectively.
C a th e p s in  D G e n e  E x p re s s io n  (N orm alised  with 
GAPDH)
1 0 0 -
9 0 -
8 0 -
7 0 -
S
I  6 0 -
“ J 5 0 -
5
I -
—  Medium Only
M ♦ P O S  1 x 10s /ml 
M + P O S  1 x 10 7/ml 
■ ■ ■  MGEL Only 
E E 3 M G E L +  P O S  1* 10*/ml
m m  m g e l + p o s  ix  io '/m i
150G A + PO S 1 x 10e/ml 
150G A + PO S 1x 107/ml
Day
CAB G e n e  E x p r e s s i o n  ( N o r ma l i s e d  wi th GAP DH)
m—m M e d iu m  O n ly
M ♦ P O S  1 x 1 0* /m l 
KSSSI M ♦ P O S  1 x 1 0 T/ml ■ ■  M G E L  O n ly 
S M G E L *  P O S  1 x 1 0®/mI 
10
C — 1 1 5 0 G A » P O S  1 x 10 B/m l 
S f f l l S 0 G A  + P O S  1> 1 0 ’ nel
_ ________ 6 .
1.00 70 0  14.00 28.00
125
The Critical Role o f  AGEs/ALEs in A ee-Related Dysfunction o f the Retinal Pigm ent Epithelium Chapter 4
A P S  G e n e  E x p r e s s i o n  ( N o r ma l i s e d  wi t h GAPDH)
50-.
40 -
E2SS3 M G E L *  P O S  1 x  1 0 e / ml  
E 2 2 2 M G E L +  P O S  1 x 1 0  Itn I 
H 1 5 0 m M  G A  
I ■ 1 5 0 G  A + P O  S  1 x 1 0®/ ml
r  1 i * * n f i A  +  p n R  1 »  r n 7 / m i
|
I 30-
Q-
X
U1e
>
2 0 -
£.
- i h l
2801.0 70 14.0
Day
Figure 4.6 ARPE 19 cell cultured on with and without glycated matrigel and 
relative gene expression o f Cathepsin D (A) (It had [2.43/56.81f  95.7% decrease at cells 
treated with 150mM GA fed  with lx l0 7/ml POS compared with control); Cathepsin B (B) 
(It had [246/0.25] 984fold increase at cells treated with l50mM GA fed with lx l0 7/ml POS 
compared with control) and Acid Phosphatase (C) (It had [  4.89/0.69J 7.08 folds increase 
at cells treated on 15OmM GA fed with 1x10'/ml POS compare with control) were analysed 
by Real-time PCR.
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4.3 Discussion
The formation of AGEs, such as CML and pentosidine is accelerated in 
regions of oxidative stress (Stitt et al., 1997). Age has been implicated in AMD's 
pathogenesis, accumulation in ageing and AMD retinas at pathologic sites in 
Bruch's membrane and the RPE (Stitt et al., 1998 &2000). AGE formation within 
extracellular matrices has been proposed to contribute to diminished barrier and 
filtration properties in Bruch's membrane. Glycosidation and lipoxidation reactions 
induced by oxidative stress have been linked to drusen formation and are proposed to 
contribute to the progression of AMD.
One of the most significant age-related changes in the RPE is the 
accumulation of lipofuscin. Each individual cell of the RPE is thought to 
internalize and degrade up to 200-4000 outer segment discs per day (Bok & Young 
1969). Therefore it might have been expected to see changes in the expression of 
genes associated with the degradation of outer segment material, such as lysosomal 
enzymes.
I have shown for the first time that AGEs have a deleterious influence on 
the highly active and uniquely specialised lysosomal system in the RPE. However, 
it remains to be determined whether AGEs could be abnormal or subject to up or 
down regulation of the related lysosomal enzymes gene expression in the RPE 
under certain pathological conditions with ageing. J. T. Handa et al (1999) 
demonstrated that ARPE-19 cells in vitro grown on Growth Factor Reduced 
Matrigel modified by AGEs could induce an altered mRNA phenotype. They also 
found there were up regulated expression of AGE-receptors (Receptor 1 and 
Receptor 3) at the RNA and protein levels in the RPE cells compared to RPE
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associated with morphologically normal Bruch's membrane which were related to 
AGEs exposure with ageing (Handa et al., 2001). The authors reasoned that genes 
relevant to a phenotype were tightly regulated and had constant expression, so that 
small expression changes would produce biologically important differences (Handa 
et al., 2001). This supposition had particular relevance when determining 
topographically related changes since we would expect to find small expression 
changes by regional location.
This suggested that AGEs might induce an ageing mRNA phenotype to the 
RPE that would promote the lysosomal enzyme gene expression and further to 
promoted degeneration of the RPE-Bruch’s membrane complex which related with 
AMD in ageing. Cathepsin D was considered to be the main protease involved in the 
digestion of photoreceptor outer segment (Regan et al 1980). However, their 
expression in RPE had not been previously investigated. In the present study, as 
initial work to address our hypothesis, we used real time RT-PCR analysis method to 
investigate AGE modulation of the lysosomal enzymes gene expressions in the RPE. 
The RT-PCR approach allowed us to examine relative quantity changes of gene set, 
which uncovered an expression profile that could influence ageing of RPE cells. Our 
RT-PCR analysis indicated that expression levels of Cathepsin D was 
down-regulated after exposure to photoreceptor outer segment and AGEs (figure 
4.6a). There was an exception that the CAD gene expressions affected by AGEs at 
day 7 had a dramatically decrease but compared with the enzyme activity in Chapter 
3, it had a sharp increase. A new question is raised to clarify what is the inner 
mechanism regarding these differences and future study seems necessary.
Generally, the decreased of gene expression of CAD matched our previous 
results of the enzyme activity which decreased with ageing after 28 days treatment
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with AGEs. However, it was inconsistent with a previous study that found Cathepsin 
D expression was not impaired by AGE treatment (Rakoczy et al., 1999) and that it 
was constitutively expressed at a high level in the RPE (Cavaney-Brooker & 
Rakoczy 1999).
It has been shown that Cathepsin B can participate in tumour invasion by 
degradation of extracellular matrix components (Tersariol et al., 2001). This can 
take place either intracellular by heterophagosomal activity of tumours cells 
(Sloane B.F. 1996) or extracellular by cell surface associated Cathepsin B (Sloane
B.F. 1986). It has been demonstrated that the presence of Cathepsin B at plasma 
membrane results in focal dissolution of extracellular matrix proteins and enables 
the tumour cell to invade. From our results, it supported our hypothesis that 
Cathepsin B activity was increased and the gene expression was over expressed 
after AGE treatment compared with non-glycated condition in vitro, which might 
suggest it had an important role in retinal degeneration which could be related to 
AMD pathogenesis.
Acid phosphatases are widely found in nature but normally at a low 
concentration in humans. Although they have similar function, APS differ widely 
regarding tissue and chromosomal origin, molecular weight, amino acid homology, 
sequence length, and resistance to L(+) tartrate and to fluoride. Nadler and Egan 
(1970) reported deficiency o f total lysosomal acid Phosphatase was an autosomal 
recessive disorder. Over expression of APS in man was also found to be related to 
a pathophysiological process for example in prostate cancer, Gaucher’s disease-an 
inborn error of cerebroside metabolism that was inherited as a recessive disorder 
etc. In this study, Acid Phosphatase was over expressed especially after AGEs 
treatment, this work addressed the hypothesis.
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A glimpse at the diversity of gene expression alterations induced by AGEs 
was made possible with a high throughput approach. Further work characterizing 
AGE-induced changes, determining what changes were “causes or effects,” and 
identifying an AGE mediated ageing effect to the RPE in vivo is warranted and 
underway. In our results, although the fold changes induced by AGEs were 
moderate before 14 days but were considerable higher after 28 days treatment at 
the end, we confirmed the expression patterns of gene expression by RT-PCR. This 
analysis identified genes that were previously not known to be regulated by AGEs, 
expressed by RPE cells, or implicated in ageing changes.
Further in depth studies are required before speculating if there is any 
functional change associated with the differentially expressed genes. However, the 
large number of differentially expressed genes emphasizes the difficulty of 
interpreting results based on a single cell line and indicates the need for additional 
study before making suggestions about what may happen in vivo. Caution must be 
used in fully comparing the AGE-induced gene expression profile found in this 
study to ageing of the RPE or AMD. Although the ARPE-19cell line has been 
characterized in depth and displays many of the characteristics of the RPE in vivo, 
making generalizing statements referring to the in vivo situation, which presumably 
can only be justified after the study of multiple cell lines or even in primary cells.
We acknowledge that matrigel, the best-known basement membrane 
approximation in vitro could induce artificial gene expression changes or that 
nonphysiologic AGEs could be produced by glycolaldehyde and to be used for in 
vitro research purposes.
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5.1 G e n e r a l  D is c u s s io n  a n d  C o n c l u s io n s
Ageing is considered to be one of the most important risk factors for the 
development of AMD. It has been defined as “the progressive accumulation of 
changes with time that are associated with or responsible for the ever-increasing 
susceptibility to disease and death which accompanies advancing age” (Harman 
1981). The accumulation of lipofuscin in the RPE is one of the major markers of 
ageing in the retina. Retinal pigment epithelial lipofuscin originates largely from 
the shed tips of photoreceptor outer segments, and it begins to accumulate in retina 
since childhood (Katz et al., 1986; Boulton et al, 1991). They are phagocytized 
throughout life, producing an incompletely degraded residuum that accumulates in 
the end stage lysosomes of RPE (Feeney 1978). This is reflected by increasing 
accumulation of auto-fluorescent granules in the RPE cell. They are considered to 
represent lipofuscin derived from autophagy developed in several types of cultured 
cells (Gao et al., 1994). Incomplete degradation of POS is thought to contribute to 
RPE lipofuscin accumulation (Boulton et al., 1989).
Maintenance of RPE cultures at confluence and feeding with POS has 
been identified as a useful model to identify the ageing process in the RPE in vitro. 
These issues were addressed in our results both in the ARPE-19 cell line and 
primary cells from aged donors. From our results, the accumulation of auto- 
fluorescent granules increased moderately after 28 days culture without feeding 
POS but showed a dramatically increase in the cells feeding with highest POS 
(p=0.0081). Results for primary cells showed the similar trend. It was also shown 
the changes had no significant gender differences. Unfortunately, during this time,
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it was impossible to get primary cells from younger donors. We could not confirm 
the hypothesis that if the age variance had a key role in the accumulation of auto- 
fluorescent granules in the RPE; future work should address this issue depending 
on donor’s availability.
A great amount of evidence has shown that advanced glycation can also 
play a considerable role in age-related RPE dysfunction (Kasper et al 1999; 
Sebekova et al., 1998). Because the accumulation of advanced glycation end- 
products in the RPE has been addressed, it is a normal process of ageing. It is 
possible that any interfering effects which increase the accumulation of AGEs at 
the RPE-Bruch’s-choriocapillaris interface during ageing may contribute or 
facilitate the development of AMD and relate degenerative disorders in the ageing 
patient.
It is well known that AGEs can mediate a wide range of cellular 
responses, such as increased deposition o f lipofuscin within RPE; altered RPE cell 
lysosomal enzymes activities; reduced cell phagocytosis ability; changed the cell’s 
oxidative stress ability (Boulton et al., 1998) and altered ageing mRNA phenotype 
(Handa et al, 2001). Each of these responses induced by AGEs could be 
considered as an important component, which could contribute to age-related RPE 
dysfunction. Therefore, we assessed each of these AGE effects individually.
It was hypothesised that the advanced glycation may be involved with 
the pathogenesis of age-related dysfunction of the Retinal Pigment Epithelial; for 
example, age-related macular degeneration-AMD. This hypothesis was developed 
from previous findings that showed AGEs were present in drusen and accumulated 
in Bruch’s membrane during ageing (Handa et al 1995, Ishibashi et al 1998). On
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the other hand, there were a few in vitro studies had demonstrated that exposure of 
the RPE to AGEs had shown a range of latent important pathogenic responses (Lu 
et al 1998, Handa et al 1998, Honda et al 2001). Therefore, to investigate the 
effects of advance glycation end-products on retinal pigment epithelial cell layer in 
vitro is a relevant and timely approach to understand how it affects the RPE with 
ageing. It will also help us to understand many other important age-related 
diseases for further research of this pathogenic mechanism within the context of 
RPE ageing. This may lead to exploration of a novel method for the future 
therapy.
In order to quantify the overall effect of the non-enzymatic glycation on 
RPE function, we evaluated the effect of AGE exposure at a molecular and 
cellular level. The cellular level investigations involved in vitro assays, such as 
exposure of the RPE (cell line and primary cells from donors) to AGEs to bring 
about the damaging effects to induce the different abnormal cellular responses. 
Therefore, to investigate this issue, the RPE monolayer was grown on AGE- 
modified basement membrane extract (matrigel ™ substrate) formed via 50- 
200mM glycolaldehyde treatment for up to 28days. This approach is of proven 
value within in vitro systems and represents an excellent model o f the aged, cross- 
linked extracellular matrix (Paul R.G, Bailey A.J. 1996, Xamamoto H. 1997).
There were significant increases o f accumulation of auto-fluorescence 
granules within the RPE were observed in our experiments, which were 
manifested in two ways. Firstly, there were significant morphological changes 
observed under a light microscope, especially after cells exposed to the AGE 
modified matrigel after 28 days culture. We believe this is the first time that the
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visible changes of RPE cells under ageing conditions with glycation treatment 
have been observed. Secondly, flow cytometry analysis also revealed these ageing 
changes and they were significant induced by AGEs. It appeared to be consistent 
with a recent preliminary report that indicated greater auto-fluorescence in human 
RPE that were brought to replicative senescence in vitro (Cabral et a l, 1990). 
However, this outcome appeared to conflict with findings in bovine RPE; this 
might be due to species differences (Skumatz et al., 1998). Older human donors’ 
RPE cells were also used in the current study and showed similar results compared 
with the cell line. Donor age variance in this study could not be tested to monitor 
the affect on the development of auto-fluorescence in vitro because there were no 
young donors’ RPE cells available.
In addition to the effect of AGEs on RPE cell dynamics, it was 
hypothesized that AGEs could be trafficked to the lysosomes where they could 
affect RPE function, possibly through accumulation in lysosomal compartments 
leading to a reduction in derivative capacity and then possibly leading to 
lipofuscin formation. Incomplete proteolysis in lysosomes was thought to 
contribute to lipofuscin accumulation in RPE in situ (Feeney 1978). We have 
demonstrated that lipofuscin is capable o f inhibiting lysosomal enzyme activity in 
both biochemical assays (Boulton et al., 1998) and using in vitro models (Boulton 
et al., 2001). RPE accumulation of lipofuscin and dysfunction of lysosomal 
degradative capacity may be related to AGE formation in vivo. Kasper et al., have 
demonstrated AGE-mediated dysfunction of Cathepsin D expression and 
enzymatic activity in lung epithelium (Kasper et al., 1999) and Cathepsin B, L and
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H also show reduced proteolytic activity after exposure o f kidney epithelial cells 
to AGE-albumin (Sebekova et al., 1998).
We therefore considered the possibility that AGEs/ALEs may have a key 
role in the formation of auto-fluorescent inclusion in the RPE, and may result from 
reduced lysosomal activity in vitro, causing the accumulation of autophagic 
materials. This is important because the primary function of the RPE is to 
phagocytose and degrade POS. We selected the aspartic proteinase Cathepsin D as 
a marker enzyme of lysosome because it is widely regarded as the most important 
protease in this process (Regan et al., 1980); Cathepsin D also has a high activity 
in RPE cells. This enzyme has already been implicated in age-related dysfunction 
(Boulton et al., 1994).
From our results, Cathepsin D activities increased during the first 14 
days of treatment after confluence and this was contradicted with previous reports. 
From 14-28days culture, the enzyme activities showed a significant decrease. This 
was consistent with the report of Boulton (et al., 2001). The important issue from 
this study was that the decrease did not show glycation concentration dependence, 
but was time and POS-dose dependent. It could be possible that the AGE 
concentration scales used in this study may be too high even at the lowest scale 
(50mM); low glycation conditions are suggested for the future study. Also the 
RPE cells could possibly produce auto-fluorescent inclusions as they digest 
material. As they eat up the matrix if there were lysine reactions occurring 
with free aldehydes intermediates and e.g. lysines in the matrix, the auto- 
fluorescent granules can be formed so they are called lipofuscin like fluorophores. 
There shouldn't be much, only loads more with the glycated matrices.
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Results were also confirmed using primary cells from donors. This may 
also suggest that increased lysosomal enzyme activity may help prevent 
accumulation o f auto-fluorescent materials in growing cells, which could lead to a 
new therapeutic method for AMD.
Cathepsin B activities were also studied, results showed a decrease for 
the first 14 days but an increase after 14 days to reach a peak at 28 days. The 
changes were glycation concentration and POS-dose dependent. It had a difference 
compared with the report by Sebekova et al., (Sebekova et al., 1998). APS 
activities had a big variation during the different culture time. Without glycation, 
the enzyme activity finally increased after 28 days feeding with POS, which was 
in contradiction with previous results (Sebekova et al., 1998). This may be 
because the time period used in our experiments was longer. The APS activities 
showed a significant decrease at 28 days after glycation treatment (50mM GA
n
feeding 1x10 /ml POS, p=0.0021 compare with control). As there were so many 
reports regarding the APS activity difference in vitro, further research may be 
necessary to be performed in different cell types. Having investigated the effects 
of AGEs on Cathepsin D, B and Acid Phosphatase activity, further studies should 
also concentrate on the many other RPE lysosomal enzymes.
Ageing is a complex phenomenon. It depends on the interaction among 
of numerous genes, cellular pathways and environmental risk factors. Real time 
RT-PCR has been developed to use for analysis changes in patterns in the gene 
expression of ageing retina in a few patients (Yoshida et al., 2002). It is important 
to determine whether there is a genetic basis for ageing associated retinal diseases 
such as AMD, via a hypothesis-independent profile. Several genes involved in cell
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growth and protein processing are preferentially expressed in the retina of young 
patients, where as genes involved in stress responses and energy metabolism play 
key roles in retinal ageing (Yoshida et al., 2002). The analysis of gene expression 
in pathological ageing tissue by using of real time RT-PCR may lead to the 
identification of specific genes responsible for these diseases.
Previous studies have demonstrated that AGEs can influence the 
behaviour of RPE cells in vitro by inducing the expression of abnormally high 
levels of the growth factors PDGF-B and VEGF (Handa et al 1998, Lu et al 1998) 
and mRNA phenotypes (Handa et al., 2001). We hypothesized that AGEs could 
also influence cell dysfunction via tertiary modification of essential gene 
expressions of lysosomal enzymes, which are important for regulating cell 
responses such as phagocytosis of POS and maintains the RPE normal function.
Results from this aspect of the study have found that AGE-modification 
of the expression of genes significantly affects RPE behaviour, in terms of 
impaired phagocytosis and maintenance of RPE. The fold changes in CAB, CAD 
and APS were dramatic. For example, the cells treated with 150mM glycation 
concentration feeding with lx l0 7/ml POS, showed gene expression changes in 
CAB 700 fold greater than control; in CAD, it was a 70% decrease and it was 12 
times higher than control for APS activities. Since Bruch’s membrane is known to 
accumulate AGEs and become increasingly crosslinked with age (Handa et al. 
1999; Farboud et al. 1999; Verijl et al. 1998), AGEs may therefore have an 
important role inducing RPE dysfunction with implications for the pathogenesis of 
many RPE-related disorders.
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The pathological ageing of the retina is a complex phenomenon that 
should benefit from therapeutic interventions such as the modification of risk 
factors (for example antioxidant oral supplements for AMD patients) to prevent 
disease progression, and the modification of intermediated disease mechanisms. 
We originally proposed that AGEs could play a very important role in the age- 
related dysfunction o f the retinal pigment epithelial in humans. In our conclusion, 
it had been shown that there was some evidence from different methods of in vitro 
study to indicate that AGEs appear to contribute to RPE dysfunction with ageing. 
In summary, it has been demonstrated that the molecular and cellular function of 
the RPE could be transformed by non-enzymatic glycation. All these results 
supported the fact that AGEs had a considerable vital role in age-related RPE 
dysfunction. However, it was not possible to completely address the hypothesis 
that AGEs were responsible for the development of age-related disease in the RPE.
Of course, although AGEs may not have contributed to the cause of age- 
related retinal disease, they certainly promoted the progression of age-related 
retinal disease. This will help us to develop a new strategy to investigate new 
drugs to prevent or decrease the accumulation of AGEs in the outer retina, which 
will restrict the dysfunction of RPE in ageing patients. To date there are many 
drugs, such as AGE inhibitors and cross linking breakers under development and 
in use for a wide range o f diabetes and age-related disorders. However, there is 
relatively little attention given toward them for a potential use in the eye related 
ageing dysfunction field o f research. Further research in the future would help to 
promote a few new therapeutic choices for treatment or take precautions against 
age related macular degeneration and age-related outer retina dysfunction.
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Appendix I: materials and suppliers
Acetone 
Acetic acid 
Agrose powder 
Ammonium hydroxide 
Benzylpenicillin 
BCA-Kit
Bovine serum albumin 
Citric acid 
Chloroform
Diethylpyrocarbonate (DEPC)
Dimethyl sulphoxide
DL-Tyrosine
EDTA
Ethanol
Ethidium bromide
Fetal calf serum
Formaldehyde
Fungizone
Glycerol
Glutamine
Glycoaldehyde
Haemoglobin
Ham’s F10 growth medium 
HEPES buffer solution
Sigma-Aldrich 
Acros Organics 
Sigma
Sigma-Aldrich 
Sigma Chemical Co 
Pierce Biotechnology 
Gibco
Acros Organics 
Sigma Chemical Co 
Sigma chemical Co.
Sigma Chemical Co 
Sigma-Aldrich 
Sigma Chemical Co 
Sigma-Aldrich 
Sigma
TCS Biological Ltd 
Sigma
Sigma Chemical Co 
Sigma
BDH Laboratory Supplies
Sigma-Aldrich
Sigma-Aldrich
Gibco BRL(life Technologies Ltd.) 
Gibco
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Hydrochloric acid
Isopropanol
Magnesium chloride
Matrigel
Methanol
MOP powder
Penicillin powder
p-N itropheny lpho sphate
PBS Buffer tablets
Pepstatin
Potassium chloride 
Potassium phosphate 
Sodium bicarbonate 
Sodium Borohydride 
Sodium chloride 
Sodium citrate 
Sodium Formate 
Sodium hydroxide 
Sodium phosphate 
Streptomycin sulphate 
Sucrose 
TCA
Tris-acetate 
Trypsin 
Triton X-100
BDH Laboratory Supplies 
Sigma
BDH Laboratory Supplies
Becton-Dickinson
Sigma Chemical Co
Sigma
Sigma
Sigma
Sigma
Sigma
BDH Laboratory Supplies
Acros Organics
BDH
Sigma-Aldrich
BDH Laboratory Supplies
Sigma
BDH Laboratory supplies 
BDH Laboratory Supplies 
BDH Laboratory Supplies 
Sigma Chemical Co 
BDH Laboratory Supplies 
BDH Laboratory Supplies 
Sigma Chemical Co 
Sigma
Sigma Chemical Co
A ppendix
Trypsin Sigma Chemical Co
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